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Figure 1.1. Schematic illustrating the general design of a targeted drug 
delivery platform.  The drug and targeting moiety are attached 
to a scaffold.  The choice and drug and targeting moiety are 
dependent on the type of cancer being treated.   
 
8 
Figure 1.2. Cartoon showing a mica-supported 1,2-Dimyristoyl-sn-
Glycero-3-Phosphocholine (DMPC) lipid bilayer.  DMPC 
supported lipid bilayers serve as the model membranes used in 




Figure 2.1. Dissociation constants (KD) obtained using SPR for a series of 
G5-FAn.  This data was obtained by S. Hong.   
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Figure 2.2. Graph showing a linear increase in ka and exponential decrease 
in kd with increasing number of FAs, n.  This data was 
obtained by S. Hong and analyzed by P. Leroueil.   
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Figure 2.3. The effect of the number of FAs, n, on G5-FAn binding as 
previously measured by surface plasmon resonance (SPR) and 
fluorescent activated cell sorting (FACS) (S. Hong).  Note that 
blue circles and red squares represent SPR and FACS results, 
respectively. The error bars represent standard deviations. The 
nanodevice with 2.6 FA shows a lower degree of cellular 
binding and association constant KA than the rest of the 
nanodevices. FACS data were obtained after incubation with 
dendritic nanodevices with FAR over-expressing KB cells at 
37ºC and represent averaging from 12 different samples at 
each condition. Association constants were averaged values 
from at least three SPR measurements for each point. The 
association constant (KA =1/KD) is plotted in this case as it 




Figure 2.4. Depiction of experimental set-up.  A G5-FAn dendrimer is 
attached to an AFM tip (gold) via a PEG linker (tan).  Here, 7 
FAs (red) are conjugated to the surface of the G5 dendrimer.  
During force-pulling measurements, the AFM tip is lowered, 
allowing the G5-FAn to interact with the FBP substrate 
surface.  The number of FAs per G5-FAn that bind to the FBP 





FA-FBP bonds are ruptured.  This process is repeated until 
2000 force-distance curves are obtained.  
  
Figure 2.5. Force (pN) vs. distance (nm) curves showing (a) specific G5-
FAn binding to the FBP substrate and (b) specific G5-FAn and 
partial unbinding in the form of a ‘dislocation.’  Rupture 
forces were extracted from force-distance curves by 
determining the magnitude of (a) (d-c) and (b) (d-c) and (f-e). 




Figure 2.6 Histogram of rupture forces spanning 0-0.8 nN for G5-Ac70-
FAn at low density G5-Ac70-FAn coverage.  The maximum 
number of counted events occur at 0.68 (G5-Ac70-FA0), 0.08 
(G5-Ac70-FA2.7), 0.22 (G5-Ac70-FA4.7) and 0.21 nN (G5-Ac70-
FA7.2).  Mean measured rupture forces are 0.66 (G5-Ac70-
FA0), 0.14 nN (G5-Ac70-FA2.7), 0.24 (G5-Ac70-FA4.7) and 0.23 
nN (G5-Ac70-FA7.2).  Median measured rupture forces are 0.67 
(G5-Ac70-FA0), 0.08 nN (G5-Ac70-FA2.7), 0.26 (G5-Ac70-
FA4.7) and 0.23 nN (G5-Ac70-FA7.2).  The median and means 
presented here are based on the 0-0.80 nN force region. 
34 
 
Figure 2.7 Histogram of rupture forces spanning 0-0.96 nN for G5-Ac70-
FAn at high density G5-Ac70-FAn coverage.  The maximum 
number of counted events occur at 0.16 (G5-Ac70-FA2.7), 0.14 
(G5-Ac70-FA4.7) and 0.18 (G5-Ac70-FA7.2).  Mean measured 
rupture forces are 0.58 (G5-Ac70-FA2.7), 0.37 (G5-Ac70-FA4.7) 
and 0.49 nN (G5-Ac70-FA7.2).  Median measured rupture 
forces are 0.31 (G5-Ac70-FA2.7), 0.25 (G5-Ac70-FA4.7) and 
0.33 nN (G5-Ac70-FA7.2).   The median and means presented 
here are based on the 0-0.96 nN force region.
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Figure 2.8. Histogram of rupture forces spanning 0-0.8 nN following 
incubation with free FA for G5-Ac70-FA7.2 at low density 
coverage.  This is a 56% reduction in counted force events as 
compared to the measurement performed with no free folic 
acid present for the 0-08 nN region and a 63% reduction for 
the 0-0.4 nN region.  For the 0-0.8 nN region, the average 
measured rupture force in the presence of 10μM free FA was 
0.35 nN while the median rupture force was 0.31 nN for 
rupture forces.  For the 0-0.4 nN region, the average measured 
rupture force in the presence of 10μM free FA was 0.26 nN 
while the median rupture force was 0.26 nN.
36 
  
Figure 2.9. Histogram of dislocations obtained for G5-Ac70-FAn at low 





force was 0.26 nN (G5-Ac70-FA2.7), 0.10 nN (G5-Ac70-FA4.7), 
and 0.14 nN (G5-Ac70-FA7.2). The median dislocation rupture 
force was 0.26 nN (G5-Ac70-FA2.7), 0.08 nN (G5-Ac70-FA4.7), 
and 0.13 nN (G5-Ac70-FA7.2).  The median and means 
presented here are based on the 0-0.96 nN force region.   
  
Figure 2.10. Histogram of dislocations obtained for G5-Ac70-FAn at high 
density G5-Ac70-FAn coverage.    The mean dislocation rupture 
force was 0.35 nN (G5-Ac70-FA2.7), 0.22 nN (G5-Ac70-FA4.7), 
and 0.29 nN (G5-Ac70-FA7.2). The median dislocation rupture 
force was 0.28 nN (G5-Ac70-FA2.7), 0.18 nN (G5-Ac70-FA4.7), 
and 0.24 nN (G5-Ac70-FA7.2).  The median and means 
presented here are based on the 0-0.96 nN force region. 
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Figure 2.11. Schematic distinguishing between high density G5-Ac70-FAn 
coverage and low density G5-Ac70-FAn coverage.  Force-
distance curves below each schematic serve as an experimental 
distinction between the two degrees of coverage.  Note that 
‘high density’ coverage results in multiple PEG stretches 
whereas ‘low density’ coverage results in a single PEG stretch.  
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Figure 2.12. Histogram of rupture forces obtained for G5-Ac70-FAn at low 
density coverage spanning rupture forces from 0-0.40 nN.  
Ruptures above 0.40 nN are believed not to be FA-FBP 
specific.  The mean rupture forces for G5-Ac70-FA2.7, G5-
Ac70-FA4.7, G5-Ac70-FA7.2, and G5-Ac70-FA7.2 are 0.12, 0.22, 
0.21 nN respectively.  The median rupture forces for G5-Ac70-
FA2.7, G5-Ac70-FA4.7, G5-Ac70-FA7.2, and G5-Ac70-FA7. are 
0.10, 0.21, 0.21 nN respectively.   
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Figure 2.13. Expected Poisson distribution of FAs on a dendrimer within a 
solution of G5-Ac70-FAn.  This analysis was based on the 
random addition of FA to the surface of the G5 dendrimer with 
110 available conjugation points until there is an average of n 
FAs per G5-Ac70-FAn.   
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Figure 2.14. Schematic depicting the possibility that the saturation of 
binding seen in both the SPR and force pulling studies is due 
to steric inhibition  of the entire G5-Ac70-FAn once some 
number of FAs has bound.  Figure 2.14 shows that this 
inhibition occurs at 5 FA-FBP interactions but this does not 
necessarily need to be the case.   
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Figure 2.15. Schematic depicting hypothesis as to why the average rupture 
force between a G5-Ac70-FAn and FBP substrate increases in 





binding to the receptor surface is intended only to illustrate the 
idea of ‘more’ and ‘fewer’ FA-FBP bonds.  It is believed that 
the higher rupture forces represent ‘more’ FAs binding to the 
FBP substrate than the lower rupture forces.  Because of the 
difference in local concentration between those G5-Ac70-FAn 
that are binding via ‘more’ FAs versus those that are binding 
with ‘fewer’ FAs, those bound via ‘more’ are more likely to 
displace the free FA bound to the FBP substrate.   
  
Figure 3.1. The structures of the linear polycationic nanoparticles used 
within these studies.   
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Figure 3.2. AFM images of supported DMPC lipid bilayers upon exposure 
to poly-L-lysine (PLL).  20 L of 10 g/ml PLL injected 
following image a), resulting in a final concentration of ~1.0 
g/ml in the AFM liquid cell.  Total time between a) and c) is 
approximately 50 minutes.  Several dotted white circles 
indicate formation of new holes in the lipid bilayers caused by 
PLL.  Bar: 500 nm.  Z-scale: 20 nm. 
64 
  
Figure 3.3. AFM images of supported DMPC lipid bilayers upon exposure 
to poly(ethylenimine) (PEI).  20 L of 5g/mL PEI injected 
following image a) resulting in a final concentration of ~0.5 
g/mL.  An additional 20 L of 10 g/mL was injected after 
b), resulting in a final concentration of ~1.5 g/mL.  Total time 
between a) and c) is approximately 40 minutes.  Note that 
there is no new hole formation but instead the pre-existing 
defects are expanded (see white arrows).  Bar: 500 nm.  Z-
scale: 20 nm. 
64 
  
Figure 3.4. AFM images of supported DMPC lipid bilayers upon exposure 
to diethylaminoethyl-dextran (DEAE-DEX).  50 L of 5 
g/mL DEAE-DEX injected following image a), resulting in a 
final concentration of ~1.3 g/mL.  Total time between a) and 
c) is approximately 90 minutes.  Unlike that PLL and PEI 
create or expand defects in the lipid bilayers, DEAE-DEX 
induces membrane thinning.  The newly formed defects are 2-
4 nm deep instead of complete removal of the lipid bilayers 
(~4-5 nm deep).  Bar: 500 nm.  Z-scale: 20 nm.  Elizabeth 
Janus is acknowledged for her help in obtaining these images. 
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Figure 3.5. Cell viability determined by XTT assay of a) KB and b) Rat2 
cells after incubation with PLL, PEI, DEAE-DEX, and G5-
NH2 PAMAM at 37 °C for 4.5 hrs.  Note that all the polymers 
are not cytotoxic up to a concentration of 12 g/mL  Note that 






Figure 3.6. Dose-dependent LDH release from a) KB and b) Rat2 cell 
lines incubated with PLL, PEI, DEAE-DEX, G5-NH2 
PAMAM, PEG, and PVA at 37 °C for 3 hrs.  All the 
polycationic polymers induce LDH leakage but the neutral 
polymers PEG and PVA do not cause any significant leakage.  
Note that these studies were completed by S. Hong. 
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Figure 3.7. Dose-dependent luciferase (LUC) release from Rat2pLUC cell 
line incubated with PLL, PEI, DEAE-DEX, G5-NH2 
PAMAM, PEG, and PVA at 37 °C for 3 hrs.  Before the 
incubation, Rat2 cells were transfected by PAMAM dedrimer-
mediated cell transfection to express LUC in their cytosols.  
As seen in the LDH assay data in Figure 6, all the polycationic 
polymers used in this study also cause LUC leakage but the 
neutral polymers do not.  Note that these studies were 
completed by S. Hong. 
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Figure 3.8. Confocal microscopy images of Rat2 cells incubated with a) 6 
μg/ml PLL-FITC and b) 12 μg/ml PLL-FITC conjugates.  c) A 
zoomed-out image of b).  Rat2 cells incubated with d) 6 μg/ml 
G5-NH2-FITC and e) 12 μg/ml G5-Ac-FITC conjugates.  f) 
Differential interference contrast (DIC) image of e), shown to 
illustrate that cells are present at the focal plane although 
nothing can be seen in the fluorescence image e).  Note that 
the green fluorescence from either PLL-FITC or G5-NH2-
FITC does not occur from within cell nuclei which are 
indicated by several dotted white circles.  The location of the 
nuclei and the exclusion of the polycationic polymers were 
confirmed in previously published work using DAPI staining 




Figure 3.9. Fluorescence intensity of a) propidium iodide (PI) and b) 
fluorescein (FITC) from KB cells measured by flow 
cytometer.  Note that fluorescence intensity of PI should 
increase while that of FITC should decrease with increase of 
membrane permeability.  All the polycationic polymers cause 
an increase of PI fluorescence intensities and a decrease of 
FITC fluorescence.  However the neutral polymers do not 
cause such changes.  Note that these studies were completed 
by S. Hong. 
 
67 
Figure 4.1. 4.1a).  Space filling model of MSI-78, a 22 amino acid protein 
with 9 of those residues postiviely charged at pH 7.2.  MSI-78 





final concentration of ~450 nM (1.2 mg/mL) MSI-78.  
Subsequent images over ~40 minutes were obtained (4.1c-d) 
which showed the removal of lipid, primarily through the 
expansion of pre-existing defects as seen with G5-NH2 
dendrimers.  Note that the perimeter surrounding the defects is 
~1 nm thinner then the full lipid bilayer (~5 nm).  This 
‘thinning effect’ is consistent with what had been previously 
shown at lower concentration of MSI-78 (2 μg/mL) and 
suggests that the thinning of the bilayer precedes full removal 
of lipid.  Scale bar is 500 nm.   
 
Figure 4.2. (4.2a) Space-filling model of TAT, a 275 amino acid protein 
with 50 of those residues positively charged at pH 7.2.  TAT 
protein was injected onto a DMPC lipid bilayer (4.2b) yielding 
a final concentration of 300 nN (10 μg/mL) TAT.  Subsequent 
images (4.2c-d) taken over a period of 20 minutes showed the 
formation and expansion of defects in the bilayer.  Scale bar is 
500 nm. 
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Figure 4.3. (4.3a) G3-NH2 dendron (16e+) primarily expanding pre-
existing defects, eventually accumulating around the edges 
(4.3b) G3-NH2 (32e+) accumulated around the edges of pre-
existing defects (4.3c) G5-NH2 (128e+) primarily expanded 
pre-existing defects, eventually accumulating around the edges 
and (4.3d) G7-NH2 (512 e+) primarily induced the formation 
of defects on lipid terraces.  (4.3a) G3-NH2 dendron 
concentration was ~100 nM (G3-NH2 dendron = 0.04 μg/mL).  
Dendrimer concentrations used were ~25 nM (4.3b-d) (G3-
NH2 = 0.01 μg/mL; G5-NH2 = 0.07 μg/mL; G7-NH2 = 3 
μg/mL.  Scale bars are 500 nm. (Dendrimer work was 
completed by A. Mecke 
 
85 
Figure 4.4. PEI (Mw: 78,220, PDI: 3.44, d = 6.6 nm) and DEAE-DEX 
(Mw: 18,490; PDI: 3.290, d = 4.2 nm) were injected onto 
DMPC supported lipid bilayers (4.4c and 4.4d, respectively) 
yielding a final concentration of 1 μg/mL polymer in both 
cases.  Images following injection showed that PEI expanded 
pre-existing defects (4.4e) similar to what was seen with the 
G5-NH2 while DEAE-DEX induced thinning of the bilayer 
similar to what was seen with MSI-78 at low concentration 
(4.4d).  Note that diameters were based on the Mw values and 
assuming a spherical shape with a density of 1.0 g/cm3.   
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Figure 4.5. Au-NH2 nanoparticles (4.5a) were injected onto a DMPC 
supported lipid bilayer (4.5b) yielding a final concentration of 





expanded pre-existing defects within the supported lipid 
bilayer and appeared to aggregate on the mica surface (4.5c)  
Scale bar is 500 nm.   
 
Figure 4.6. 50 nm amine coated silica spheres (~13,000 NH2/sphere) 
(4.6a) were introduced onto a DMPC lipid bilayer (4.6b) 
yielding a final concentration of ~3 mg/mL (30 nM) of the 
silica spheres.  The addition of the positively charged spheres 
resulted in the formation of circular defects on the bilayer 
ranging from 20-150 nm in diameter (4.6c).  The formation of 
the new defects within the bilayer is similar to what was seen 
with G7-NH2 PAMAM dendrimers.  Scale bar is 500 nm.    
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Figure 5.1. SDS below CMC (0.04 mM) introduced to DMPC mica-SLB 
with pre-existing defects.  (a) Image before SDS addition. (b-
d) Images post SDS addition.  Arrows highlight lipid-detergent 
boundary.  Scale bar 500 nm. 
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Figure 5.2. CTAB below CMC (0.1 mM) introduced to DMPC mica-SLB 
with pre-existing defects.  (a) Image before SDS addition. (b-
d) Images post CTAB addition.  Arrows highlight lipid-
detergent boundary.  Scale bar 500 nm. 
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Figure 5.3. Zoomed in image of  (a) 1c and (b) 2c highlighting persistent 
lipid-detergent boundaries for SDS and CTAB, respectively. 
 
104 
Figure 5.4. (a) DMPC mica-SLB after addition of SDS above CMC (20 
mM).  (b) DMPC mica-SLB after addition of CTAB above 
CMC (5 mM).  Scale bar 500 nm. 
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Figure 5.5. (a) DMPC mica-SLB after addition of CTAB above CMC (5 
mM).  (b) After addtion of SDS above CMC (20 mM) to (a).  
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Figure 5.6. CTAB above CMC deposited on mica.  Line scan shows ~2.5 
nm height for CTAB.  Scale bar 500 nm 
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Figure 5.7. Below CMC, SDS occludes defects.  (b) Below CMC, CTAB 
occludes defects.  (c)  Above CMC, SDS removes lipid from 
bilayer.  (d) Above CMC, CTAB removes lipid leaving a 
CTAB bilayer.   Note in all cases the tilt angle of the detergent 
bilayer (a, b, d) is not ascertained from these studies.  CTAB 
bilayer is drawn (b, d) based previously published studies.    
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Figure 5.8 (a) Lipid (purple) intercalated into a charged detergent micelle 








1.1 BACKGROUND  
Nanoparticles are loosely defined as structures with diameters of ~1-100 x 10-9
m.1  Invisible to the eye, and indeed most measurement techniques, nanoparticles have 
revolutionized how our cars are made, how our computer chips are made, and even how 
we play tennis.  By simply taking a piece of common material such as gold and shrinking 
it until it is very small, we can make new materials that bear very little resemblance to 
their bulk counterparts.2, 3  The potential held within these very small structures is clearly 
great, both from a consumer, as well as financial standpoint.4  In addition to infiltrating 
our everyday products, nanoparticles have changed the way we think about medicine.  
Our ability to make particles comparable in size to that of the proteins has opened up a 
wide range of possible medical applications, including gene therapy5-8 and targeted drug 
delivery.6, 7, 9-11
Despite these current and potential benefits, there is growing concern regarding 
the interaction of nanoparticles with their environment.12-19   For the most part, 
nanoparticles have been developed under the assumption that we could expect 1 kilo of 
nanoparticle X to have the same toxicity concerns as 1 kilo of bulk X.  This assumption 
would be correct if elemental composition dictated all the properties of the material.  
However, given the multitude of physical, electrical and optical properties possible using 
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the same molecule as a building block, this assumption is clearly faulty.2, 20-24  Indeed, 
nanostructure plays a key role in dictating the interactions of nanoparticles with their 
environments.  It is from this perspective that this thesis addresses the selectivity of 
targeted and non-targeted nanoparticles with cells and model cell membranes. 
1.2 TARGETED NANOPARTICLES FOR GENE AND DRUG DELIVERY
  In 1907, the Nobel Prize winning Paul Ehrlich coined the term “magic bullet” in 
reference to a compound that could selectively target and deliver toxin to an organism.25
The magic bullet has since been the holy grail of cancer treatment.26  Traditional 
treatment relies heavily on the systemic administration of highly toxic drugs that kill not 
only cancerous cells, but healthy cells as well.  Most cancer drugs possess a very narrow 
therapeutic range resulting in the need to administer sub-optimal dosages to patients.  A 
targeted drug delivery platform would allow for a patient to be given the appropriate drug 
dosage necessary to retard or stop tumor growth while minimizing non-selective side 
effects.27  In addition, targeted drug delivery would enable the patient to be given 
therapeutics in quicker succession.  This is important given that it may not be 
immediately apparent which drug or drug combination is appropriate for a particular 
cancer.  By using a targeted delivery system, the patient could be treated continuously 
with a variety of drugs without fear of doing irreparable damage to the healthy cells. 
  The field of targeted drug delivery has been largely divided into two classes of 
targeting systems: those that utilize (1) passive targeting and those that utilize (2) active 
targeting.  Passive targeting systems rely on the enhanced permeability and retention 
(EPR) effect.28  Large macromolecules are sequestered in tumors due to the leaky 
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vascular system associated with tumor growth.  The result is that nanoparticles modified 
to include traditional cancer fighting drugs are retained in the tumor, thereby selectively 
delivering the toxin to the offending cells. However, a limitation of passive targeting is 
that it requires the tumor to be of substantial size such that the surrounding vascular 
system is sufficiently compromised.29   Active targeting circumvents this problem by 
targeting not the tumor mass, but instead particular receptors or moieties present on the 
surface of individual cancer cells27 (Figure 1.1).  In principle, an active targeted platform 
will bind and internalize into only those cells which express the target.  Small molecules 
such as folic acid,10 RGD peptides,5 and aptamers30 have been employed as targeting 
agents because their respective receptors are shown to be over-expressed on a range of 
cancer cell lines.5, 31
1.2.1 Type of nanoparticles used for the development of targeted drug delivery.   
  An important component when developing a targeted drug delivery platform is 
the choice of the scaffold that serves as the backbone of the platform.  The requirements 
for an effective scaffold are that they must be: (1) highly water soluble (2) easily 
functionalizable and (3) biocompatible. An assortment of scaffolds including 
liposomes,32, 33 gold,2, 6, 34 and polymers7, 9, 10, 35 have been used in the fabrication of 
targeted platforms.  Unfortunately, however, many of these platforms fail because they 
lack one or more of the three requirements noted above.  The result is lack of directed 
toxicity at best, and unintended toxicity at worst.
1.2.2 MNiMBS development of a multivalent targeted drug delivery nanoparticle 
using a PAMAM dendrimer as a scaffold. 
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  The development of an active targeted drug delivery platform has been the focus 
of much of the Michigan Nanotechnology Institute for Medicine and Biological Sciences 
(MNiMBS).  Our group has utilized a particular type of nanoparticle called a Generation 
5 (G5) PAMAM dendrimer as our scaffold.  This nanoparticle is a highly modifiable, 
relatively mono-disperse and water-soluble branched polymer.   In addition, unlike many 
other polymers developed for targeted delivery, acetylated dendrimers have been shown 
to be non-immunogenic.10, 35
  The versatility of the dendrimer in both size and chemical termination has allowed 
for the attachment of various targeting agents (folic acid (FA), herceptin), therapeutics 
(methotrexate, taxol) and imaging agents (FITC, AlexFluor488).36   FA, the primary 
targeting agent used by our group, was chosen because its receptor, FAR, is known to be 
over-expressed on several epithelial cancer cell lines.31, 37
1.2.3 Use and Quantification of Multivalency  
  Targeted drug delivery using a single targeting agent represents a vast 
improvement over the administration of free drug.10  However, a further increase in 
targeting has been shown through the attachment of multiple FAs to the PAMAM 
dendrimer scaffold.  It was found that those devices with a larger number of FAs 
conjugated to their surface showed an increase in binding to real and model FARs (folate 
binding proteins, FBPs).38  This improvement has been quantified using confocal 
microscopy, flow cytometry and surface plasmon resonance (SPR).  Although our 
understanding of the bulk binding effects has been greatly increased using these 
techniques, they have failed to detail the interaction between a single G5-FAn and 
receptor.   
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  Chapter 2 addresses this issue using force pulling spectroscopy, a single molecule 
technique, to obtain the forces associated with the G5-FAn binding to the FBP  substrate. 
A series of G5 dendrimers with varying numbers of FA molecules (2-8) were used in 
conjunction with this technique.  It was found that the rupture force associated with the 
unbinding of these modified dendrimers from the FBP substrate scales with the bulk 
measurements previously obtained by Hong et al.38
1.3. NON-TARGETED NANOPARTICLES 
  In the process of developing our targeted platform, we found that amine 
terminated dendrimers exhibited a great deal of non-specific binding.  These interactions 
were of concern because they resulted in unintended cytotoxicity to surrounding cells.   It 
was only upon full acetylation of the terminal amines that these non-specific interactions 
were suppressed.  This was particularly interesting from our perspective because many 
‘targeted’ nanoparticles developed by other research groups suffer from the same 
selectivity issues we had when we employed non-acetylated targeted dendrimers.10  A 
hypothesis was formed that stated that the protonated amines present on PAMAM 
dendrimers at physiological pH were responsible, at least in part, for the non-specific 
interactions.  
 In order to explore the effect that dendrimer charge had on mediating non-specific 
interactions with cells, a variety of assays including enzyme leakage, dye diffusion, flow 
cytometry and confocal microscopy were employed.  These cell-level assays provided a 
relatively cheap avenue through which nanoparticle selectivity and cytotoxicity could be 
assessed.  Indeed, cell-level assays have served as the backbone for toxicity assays 
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because they address the fundamental question of “at what level does a material’s 
selectivity (or non-selectivity) result in toxicity?”  A deficiency in cell-level studies, 
however, is that they do not allow us to obtain a nanoscale understanding of the 
interaction between nanoparticle and cell.  Atomic force microscopy (AFM), in 
conjunction with supported lipid bilayers (SLBs), a simple model of the very complex 
cellular membrane, allows us to achieve nanoscale resolution of this interaction.  
Consisting of one or more types of lipid, SLBs do not contain the proteins, sugars or 
cholesterol found in a true cell membrane. (Figure 1.2) Nonetheless, this model has been 
shown to correlate with whole-cell level assays which found that cell-membrane 
disruption increased as the number of amine groups present on the dendrimer 
increased.39, 40  Given the wide range of nanoparticles currently in development, and 
indeed already on the market, we were interested in examining how other physical 
characteristics of charged nanoparticles affected their interaction with cell membranes.    
  Chapters 3-4 examine the interaction of our model cell membrane with non-
targeted nanoparticles while varying a variety of physical characteristics, including 
charge density, size, flexibility and chemistry.  By understanding the details of this 
nanoscale interaction, we can predict nanoparticle selectivity, and therefore tune their 
physical characteristics to alleviate unintended toxicity effects.  It was found that 
polycationic polymers induce defect formation and/or expansion within SLBs whereas 
neutral polymers do not.  Other types of polycationic materials (Au-NH2, Si-NH2, TAT 
protein, MSI-78) were also investigated using the AFM-SLB assay.  Each of these 
materials induce the formation and/or expansion of defects within SLBs.  Taken as a 
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whole, these studies suggest that interactions between charged non-targeted nanoparticles 
and membranes are governed grossly by surface area and charge density.35, 39, 40
  The nanoparticles investigated above are formed through covalent linkages of 
their respective sub-parts, resulting in a stable complex.  To address the importance of 
nanoparticle stability, we chose to examine charged ‘nanoparticles’ with non-stable 
structures.  Above critical micelle concentration (CMC), detergents form a non-stable 
complex (micelle) that is similar in size to those nanoparticles investigated in Chapters 3-
4.   Chapter 5 examines the interaction of two charged, non-covalently linked complexes 
with model membranes using the AFM-SLB assay.  Like the covalently linked 
nanoparticles investigated above, we find that the above CMC charged detergents SDS 
and CTAB remove lipid from SLBs.   Interestingly, pre-existing defects within the SLBs 
are occluded when these same detergents are introduced at concentrations below their 
respective CMCs.  These studies show that even transient aggregations of charged 
material are sufficient to induce hole formation in cell membranes.  
1.4. OUTLINE AND THESIS ORGANIZATION 
  This thesis details the interaction of targeted and non-nanoparticles with real and 
model membranes.  Chapter 2 addresses the binding of a targeted nanoparticle, G5-FAn
to a model cell receptor surface.  Chapters 3-5 focus on the interaction of a variety of 
non-targeted charged nanoparticles with real and model membranes.  Chapter 6 serves as 
a summary of this thesis and provides direction for relevant future studies. 
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1.5 FIGURES 
Figure 1.1.  Schematic illustrating the general design of a targeted drug delivery platform.   The drug and 
targeting moiety are attached to a scaffold.  The choice and drug and targeting moiety are dependent on the 
type of cancer being treated.       
Figure 1.2.   Cartoon showing a mica-supported 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC) 
lipid bilayer.  DMPC supported lipid bilayers serve model membrane used in all AFM studies completed 
within this thesis. 
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CHAPTER 2 
MEASURING THE BINDING OF A MULTIVALENT TARGETED  
NANOPARTICLE USING FORCE PULLING SPECTROSCOPY 
2.1. BACKGROUND 
  A limitation of many medical treatments, particularly chemotherapeutics, is that 
they are administered systemically resulting in the destruction of both sick and healthy 
cells.1, 2  The collateral damage associated with this systemic administration of drugs 
often results in premature cessation of treatment for the patient.  A device capable of 
delivering a drug to only those cells in need of treatment would be preferred.   By 
conjugating a targeting agent and a traditional therapeutic to a scaffold, one could 
selectively deliver the therapeutic to those cells expressing a particular receptor, or other 
target moiety.   
  Many targeted delivery platforms have been developed since the 1970s using a 
variety of scaffolds3-7 and targeting agents.3, 7-13   Attempts have been made to further 
increase specific binding affinity by employing multivalency, the simultaneous binding 
of multiple ligands to multiple receptors.    Previous in vitro studies using multivalent 
inhibitors have shown a 1 to 9 order increase in binding avidity over their monovalent 
form whereas multivalent effectors have shown a 1 to 2 order increase.14-19 However,
unintended targeting of healthy cells expressing the target-moiety, and non-selective 
toxicity resulting from the targeted-therapeutic remaining sequestered within the patient, 
have made many of these same targeted-therapeutics less promising in vivo. 3, 20, 21
13
  Our own group has developed a targeted platform using folic acid (FA) as a 
targeting agent, methotrexate (MTX) as a therapeutic, and an acetylated generation 5 
PAMAM dendrimer (G5) as a scaffold.  FA was chosen as the targeting agent because 
the folate receptor (FAR) is known to be over-expressed on the surface of several 
epithelial cancer cell lines.22-25  Like other targeted therapeutics, G5-FAn-MTX has been 
shown to be effective in vitro.15  However, it is the proven effectiveness of this 
multivalent (~5 FAs) platform at shrinking tumor size in vivo without causing detectable 
side effects that is truly remarkable.26
  Hong et al. recently completed a study in which the number of FAs, n, conjugated 
to the surface of a G5 was systematically varied.  Using surface plasmon resonance 
(SPR), a ~2,500- to 170,000-fold reduction in the dissociation constant (KD) over free FA 
was measured between G5-FAn (where n = ~ 3 to 14) and a model FAR (folate binding 
protein, FBP) surface (Figure 2.1).  In addition, it was found that there is an exponential 
decrease in kd with n while ka only increases linearly with n (Figure 2.2). 27 The drastic 
decrease in KD of the G5-FAn conjugates as compared to free FA is therefore due to the 
increase in residence time of the targeted-platform on the FAR expressing cell. Note that 
the enhancement in KD measured for the G5-FAn series is significantly higher than the 
10-100 fold enhancement reported by another group utilizing a different multivalent FA 
platform.28  Fluorescence activated cell-sorting (FACS) studies showed a similar trend 
(Figure 2.3).27  Given the success of this multivalent targeted therapeutic both in vitro
and in vivo, we used force pulling spectroscopy to examine in greater detail how the 




 G5 PAMAM dendrimers were synthesized and purified to remove low molecular 
weight impurities as well as high molecular weight dimers, according to previous 
reports.26, 29, 30  After purification, the dendrimers were partially acetylated (70 of the 110 
total primary amines) resulting in G5-Ac70.31 The G5-Ac70 in H2O was allowed to react 
with FA pre-activated by 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide/HCl (EDC) 
in DMF/DMSO at different molar ratios (0:1, 3:1, 6:1, 9:1) of FA to G5-Ac70.  Following 
further purification, the dendrimers were characterized.  Based on GPC and UV-Vis 
results, the following conjugates were formed: G5-Ac70-FA0, G5-Ac70-FA2.7, G5-Ac70-
FA4.7, and G5-Ac70-FA7.2.  Note that the remaining amines present on the dendrimers 
were not acetylated as they are required for the attachment to the AFM tip.   
For the purpose of this text, all discussion relating to a single G5-Ac70-FAn will be 
referred to by its bulk description.  For example, a G5-Ac70-FAn taken from a solution 
labeled ‘G5-Ac70-FA2.7’ will be denoted as a ‘G5-Ac70-FA2.7,’ regardless of how many 
FAs that particular G5-Ac70-FAn may have conjugated to its surface.   
Preparation of Biacore Substrates: 
 Folate binding protein (FBP) substrates were prepared in the same manner as 
those used in SPR binding studies.27  Substrates were prepared using a BIAcore X 
(Pharmacia Biosensor AB, Uppsala, Sweden).  FBP extracted from bovine milk was 
immobilized on the sensor chip surface of a carboxylated dextran-coated gold film (CM 5 
sensor chip) by amine coupling as described elsewhere.8, 21, 28, 32 Briefly, 70 μL of a 
mixed solution of NHS/ECD (1:1, v/v) was first injected into the BIAcore to activate the 
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carboxylated dextran, followed by injection of 70 μL of 2.5 mg/mL FBP dissolved in 100 
mM potassium phosphate buffer, pH 5.0, supplemented with 4 mM mercaptoethanol and 
10% (v/v) glycerol.  1 M ethanolamine in water, pH 8.5 was then injected to deactivate 
residual NHS-esters on the sensor chip.  The immobilization process was performed at a 
flow rate of 10 μL/min, resulting in the binding of ~6 ng/mm2  (~ 5,900 RU) of FBP per 
channel.
Preparation of AFM Tips for Forcepulling: 
 Prior to tip modification, silicon nitride (Si3N3) tips (Veeco Probes) were placed 
in a piranha solution (sulfuric acid/H2O2, 7:3) for 20 minutes.  The tips were rinsed 3 
times with Millipore water and then 3 times with 200-proof ethanol (EtOH), dried using a 
nitrogen stream and then placed in a 110°C oven for 10 minutes to remove any remaining 
water.  The tips were then silanized by suspending them in a nitrogen-purged glass vial 
for 1 hour containing a 1:15 (low density G5-Ac70-FAn coverage) or 1:5 (high density 
G5-Ac70-FAn coverage) ratio of aminopropyltriethoxylsilane (APTES) to 
methyltriethoxysilane (MTES) dissolved in chloroform.  The silanized tips were 
subsequently placed in a 110°C oven for 10 minutes.  Expected surface coverage based 
on respective vapor pressures (APTES (0.02 hPa @20˚C) and MTES (14.66 hPa 
@20˚C)) is 1:100 APTES:MTES for “low density coverage” and 1:20 APTES:MTES for 
“high density coverage”   Tips were then pegylated by placing tips in a 10 mg/mL 
solution of SMB-PEG-SMB in chloroform (Nektar) for two minutes and then rinsed 3 
times with fresh chloroform and steam dried with nitrogen.  G5-Ac70-FAn were attached 
by covering tips in a solution containing equal volumes of 1 mg/mL G5-Ac70-FAn and 
phosphate buffer (pH 8, no salts).  Tips were left undisturbed for 30 minutes and 
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subsequently washed 3 times in phosphate buffer (pH 7, no salts).  Modified tips were 
utilized the same day they were prepared and kept in a nitrogen box when not in use. 
Based on tip dimensions and APTES:MTES surface coverage, ~2 G5-Ac70-FAn (low 
density coverage) or ~6 G5-Ac70-FAn (high density coverage) were expected to be in 
contact with the FBP substrate during measurements.    
Measurements.
Using an atomic force microscope (AFM), tips modified with solutions of one of 
the four targeted platforms (G5-Ac70-FAn, where n = 0, 2.7, 4.7 or 7.2) were brought into 
contact with a FBP substrate and then retracted (Figure 2.4).  This process was recorded 
(Figure 2.5) and the force required to rupture the specific FA-FBP bonds were extracted 
as described below.  Note that forces obtained are relative and not absolute.33
Dislocation forces, which are currently thought to represent the partial unbinding of G5-
Ac70-FAn from the FBP substrate, were also extracted from those force-distance curves 
exhibiting the characteristic PEG-stretch.  Experiments were completed using an Asylum 
MFP-3D.  At low density coverage, ~2000 force-distance curves (up down motions) were 
obtained for G5-Ac70-FA0, G5-Ac70-FA2.7, G5-Ac70-FA4.7 and G5-Ac70-FA7.2.  At high 
density coverage, ~1000 force-distance curve were obtained for G5-Ac70-FA2.7, G5-Ac70-
FA4.7 and G5-Ac70-FA7.2.  The position of the tip in relation to the FBP substrate was 
changed 10 times, or after every 200 force-distance curves.  The distance retracted from 
the surface was 300-500 nm.  The rate used for these measurements was 1 Hz.  
 Blocking experiments using free FA were completed to show that the rupture 
forces measured were due to FA-FBP binding, and not simply due to non-specific 
interactions.  Blocking experiments were conducted by first incubating the FBP substrate 
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with 10 uM free FA for 40 minutes before obtaining ~2000 force vs. distance curves 
using a tip modified with G5-Ac70-FA7.2.  This experiment was completed using the exact 
same tip used for G5-Ac70-FA7.2 under low density coverage conditions.    Sensitivity and 
spring constants were calculated for each modified tip.  All measurements were 
completed in phosphate buffered solution (pH 7) using the Asylum fluid cell. 
  Extracting rupture forces from force-distance curves.  The modified AFM tips 
approached the FBP substrate (Figure 2.5-a, red) and finally contacted the surface.  The 
tip was then retracted (Figure 2.5-a, blue).  Non-specific interactions between the G5-
Ac70-FAn were first broken (a), leaving the specific G5-Ac70-FAn–bound FA-FBP 
interactions.  As the tip was pulled further from the surface, the PEG polymer linking to 
the G5-Ac70-FAn stretched resulting in the characteristic PEG-stretch (b-c) until finally 
the G5-Ac70-FAn–bound FA and FBP interactions were broken (c-d).  The force required 
to break the specific G5-Ac70-FAn – FBP interactions was extracted from the force-
distance curves by determining the difference in force-magnitude between (c) and (d).
The entire force distributions for G5-Ac70-FAn are displayed in Figure 2.6 (low density 
G5-Ac70-FAn coverage) and Figure 2.7 (high density G5-Ac70-FAn coverage). The force 
distribution for G5-Ac70-FA7.2 following blocking conditions is displayed in Figure 2.8.
 Extracting dislocations from force-distance curves.   Dislocation forces were 
extracted from those rupture force curves which exhibited both (1) a characteristic PEG 
stretch and (2) dislocation in the rupture portion of the force-distance curve.  Dislocation 
forces were obtained by determining the difference in force-magnitude between (c) and 
(d), and (e) and (f) for force distance curves similar to Figure 2.5-b. These are thought 
to correspond to the partial and complete unbinding, respectively, of the G5-Ac70-FAn
18
from the FBP substrate.   Dislocations are displayed in Figure 2.9 (low density G5-Ac70-
FAn coverage) and Figure 2.10 (high density G5-Ac70-FAn coverage).
2.3. RESULTS 
I.  Results for low-density G5-Ac70-FAn coverage
Rupture forces measured for G5-Ac70-FA0, G5-Ac70-FA2.7, G5-Ac70-FA4.7,
and G5-Ac70-FA7.2. A total of 2000 curves were obtained for a tip modified with each 
dendrimer sample.  The first force event, Figure 2.5a, region a-b, was present for 70% of 
the curves whereas the remaining 30% smoothly retracted with a discernable force 
interaction.  The second force event, region b-c-d, was present for 14 (G5-Ac70-FA0), 598 
(G5-Ac70-FA2.7), 440 (G5-Ac70-FA4.7), and 596 (G5-Ac70-FA7.2) of the curves measured.  
Histograms of the measured rupture forces for region b-c-d are displayed in Figure 2.6.
The maximum number of counted events occur at 0.68 (G5-Ac70-FA0), 0.08 (G5-Ac70-
FA2.7), 0.22 (G5-Ac70-FA4.7) and 0.21 nN (G5-Ac70-FA7.2).  Mean measured rupture 
forces are 0.66 (G5-Ac70-FA0), 0.14 nN (G5-Ac70-FA2.7), 0.24 (G5-Ac70-FA4.7) and 0.23 
nN (G5-Ac70-FA7.2).  Median measured rupture forces are 0.67 (G5-Ac70-FA0), 0.08 nN 
(G5-Ac70-FA2.7), 0.26 (G5-Ac70-FA4.7) and 0.23 nN (G5-Ac70-FA7.2).  The values 
provided in this paragraph are derived from all measured interactions presented in Figure
2.6.
Rupture forces measured following incubation of FBP-substrate with free 
FA. The incubation of 10μM free FA with the FBP substrate prior to performing force 
measurements using a G5-Ac70-FA7.2 tip resulted in 163 force events (b-d-c) from 2000 
measured curves (Figure 2.8).  This is a 56% reduction in counted force events as 
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compared to the measurement performed with no free folic acid present for the 0-08 nN 
region and a 63% reduction for the 0-0.4 nN region.  For the 0-0.8 nN region, the average 
measured rupture force in the presence of 10μM free FA was 0.35 nN while the median 
rupture force was 0.31 nN for rupture forces.  For the 0-0.4 nN region, the average 
measured rupture force in the presence of 10μM free FA was 0.26 nN while the median 
rupture force was 0.26 nN. 
Dislocations present in some force-distance curves.  Dislocations (see Figure
2.5b) were found in 0 (G5-Ac70-FA0), 3 (G5-Ac70-FA2.7), 24 (G5-Ac70-FA4.7) and 83 
(G5-Ac70-FA7.2) of the 2000 force curves taken for each G5-Ac70-FAn.  The mean 
dislocation rupture force was 0.26 nN (G5-Ac70-FA2.7), 0.10 nN (G5-Ac70-FA4.7), and 
0.14 nN (G5-Ac70-FA7.2). The median dislocation rupture force was 0.26 nN (G5-Ac70-
FA2.7), 0.08 nN (G5-Ac70-FA4.7), and 0.13 nN (G5-Ac70-FA7.2).  The distribution of low 
density coverage dislocations is displayed in Figure 2.9.
II.  Results for high-density G5-Ac70-FAn coverage
Rupture forces measured for G5-Ac70-FA2.7, G5-Ac70-FA4.7, and G5-Ac70-
FA7.2. A total of 1000 curves were obtained for a tip modified with each dendrimer 
sample.  The b-c-d- region of Figure 2.5a was present for 221 (G5-Ac70-FA2.7), 258 (G5-
Ac70-FA4.7), and 233 (G5-Ac70-FA7.2) of the curves measured.  The maximum number of 
counted events occur at 0.16 (G5-Ac70-FA2.7), 0.14 (G5-Ac70-FA4.7) and 0.18 (G5-Ac70-
FA7.2).  Mean measured rupture forces are 0.36 (G5-Ac70-FA2.7), 0.30 (G5-Ac70-FA4.7)
and 0.36 nN (G5-Ac70-FA7.2).  Median measured rupture forces are 0.29 (G5-Ac70-FA2.7), 
20
0.24 (G5-Ac70-FA4.7) and 0.30 nN (G5-Ac70-FA7.2).   The distribution of rupture forces at 
high density coverage is displayed in Figure 2.7.
Number of PEG stretches force-distance curves at high density G5-Ac70-FAn
coverage.  The number of PEG stretches found within the 1000 force curves taken for 
G5-Ac70-FA2.7 was: 0(778), 1(87), 2(67), 3(38), 4(13), 5(14), 6(1), 7(2) and 8(0).  The 
number of PEG stretches found within the 1000 force curves taken for G5-Ac70-FA4.7 
was: 0(741), 1(127), 2(78), 3(37), 4(9), 5(5), 6(0), 7(2) and 8(1).  The number of PEG 
stretches found within the 1000 force curves taken for G5-Ac70-FA7.2 was: 0(768),
1(154), 2(54), 3(30), 4(17), 5(9), 6(6), 7(1) and 8(1).  Representative force distance 
curves obtained at high and low density G5-Ac70-FAn coverage is presented in Figure
2.11.  Note the presence of multiple PEG stretches in the high density coverage example  
Dislocations present in some force-distance curves at high density G5-Ac70-
FAn coverage. Dislocations (see Figure 2.5b) were found in 53 (G5-Ac70-FA2.7), 60 
(G5-Ac70-FA4.7) and 102 (G5-Ac70-FA7.2) of the 1000 force curves taken for each G5-
Ac70-FAn.  The mean dislocation rupture force was 0.35 nN (G5-Ac70-FA2.7), 0.22 nN 
(G5-Ac70-FA4.7), and 0.29 nN (G5-Ac70-FA7.2). The median dislocation rupture force was 
0.28 nN (G5-Ac70-FA2.7), 0.18 nN (G5-Ac70-FA4.7), and 0.24 nN (G5-Ac70-FA7.2).  
Dislocation distribution obtained at high density G5-Ac70-FAn coverage are displayed in 
Figure 2.10.
2.4. DISCUSSION 
Summary of measured rupture forces after removing events not related to 
folic acid/FBP binding from low density G5-Ac70-FAn coverage. The raw data 
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summary provided above include some events that we believe are not related to FA/FBP 
binding.  The rupture force histogram (Figure 2.6) includes 14 b-c-d events for the 
dendrimer containing no FA (G5-Ac70-FA0).  These 14 events are localized in the 0.40 to 
0.80 nN force range which does not overlap with the major portion of any of the three 
histograms ascribed to FA/FBP binding for the other samples.  Furthermore, examination 
of the inhibition data (Figure 2.8) shows that forces measured in the 0.40 – 0.80 nN 
range are not reduced in count frequency by the presence of free FA.  The fact that these 
forces are present for conjugates containing no FA, and that they are not inhibited by the 
presence of free FA, indicates that these are not FA/FBP related events.  Therefore, the 
measured rupture forces are summarized below with the data in the 0.40-0.80 nN range 
excluded from the noted means and medians. The mean rupture forces for G5-Ac70-FA2.7,
G5-Ac70-FA4.7, G5-Ac70-FA7.2, and G5-Ac70-FA7.2 are 0.12, 0.22, 0.21 nN respectively.  
The median rupture forces for G5-Ac70-FA2.7, G5-Ac70-FA4.7, G5-Ac70-FA7.2, and G5-
Ac70-FA7. are 0.10, 0.21, 0.21 nN respectively.  Excluding the events in the 0.40 to 0.80 
nN range does not change the force at which the maximum number of events is counted 
for any of these samples.  Additionally, the median and average rupture force for G5-
Ac70-FA7.2 under blocking conditions excluding the events in the 0.4 nN to 0.80 nN range 
is 0.26 nN.  The distribution of rupture forces obtained between 0-0.4 nN is displayed in 
Figure 2.12
Distribution of FAs on the surface of the G5-Ac70-FAn makes assignment of 
rupture forces very difficult. A criticism of this work is that we have only used a single 
G5-Ac70-FAn per experiment to determine the binding of a nanodevice with n FAs. This 
is problematic in that the actual number of FAs on a single G5-Ac70-FAn used for the 
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force experiment can differ significantly from the average, n. Figure 2.13 shows the 
expected distribution of FAs on the G5 scaffold within a solution of G5-Ac70-FAn.  This 
analysis was based on the random addition of FA to the surface of the G5 dendrimer with 
110 available conjugation points until an average of n folic acids per conjugate was 
obtained.  This resulted in a Poisson distribution.  Note that there is a significant overlap 
in the expected distributions for the three G5-Ac70-FAn conjugates making the likelihood 
of having the stated number of FAs n present on each of the conjugates much lower than 
desired.  For example, the likelihood of obtaining a G5-Ac70-FA3, G5-Ac70-FA5 and G5-
Ac70-FA7 is less than 1 percent ((G5-Ac70-FA3 (23%), G5-Ac70-FA5 (19%) G5-Ac70-FA7
(17%)).   Recall that for the purpose of this text, all discussion relating to a single G5-
Ac70-FAn will be referred to by its bulk description.  For example, a G5-Ac70-FAn taken
from a solution labeled ‘G5-Ac70-FA2.7’ will be denoted as a ‘G5-Ac70-FA2.7,’ regardless 
of how many FAs that particular G5-Ac70-FAn may have conjugated to its surface.   
Comparison of the low density G5-Ac70-FAn coverage rupture forces to 
previously performed SPR studies. Despite not knowing the exact number of FAs 
present on the each of the G5-Ac70-FAns used for the studies, the trend seen in the low 
density G5-Ac70-FAn coverage data is remarkably consistent with trend seen in the SPR 
as well as FACs studies.  These SPR studies showed that the change in KD per FA greatly 
decreased after more than 5 FAs were added per G5-Ac70-FAn. The correlation between 
the bulk measurements (SPR and FACS) to the single molecule measurements presented 
here is interesting although not altogether understood. Two hypotheses have been put 
forward to explain the near-saturation of the KD and rupture force at ~5 FAs: (1) the G5-
Ac70-FAn can only reach ~5 FBPs and (2) the binding is sterically limited by the 
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flexibility of dendrimer platform itself  (Figure 2.14).  The first hypothesis was discussed 
in detail within the paper.27  The second, however, was not explicitly discussed but is in 
some ways correlated to the first in that the sterics are related to our choice of a G5 
PAMAM dendrimer as the scaffold.  Once some number of FAs bind to the FBP 
substrate, the remaining FAs are severely hampered in their ability to bind to the FBP 
substrate.  Due to steric constraints, a saturation in binding is obtained, regardless of how 
many FAs are present on the G5-Ac70-FAn.  One could imagine increasing the size of the 
scaffold (i.e., generation of the dendrimer) to increase the effective reach of the targeted 
platform.  This could prove helpful in cases in which targeted receptors are not closely 
situated near each other on the cell membrane surface.  The caveat to this is that larger 
dendrimer generations lose their flexibility because the density of end groups on the outer 
shell of the dendrimer necessarily increases with increasing generation.  Therefore, one 
must be cognizant of the inherent size-flexibility tradeoff when altering the nature of the 
dendrimer scaffold. 
At high G5-Ac70-FAn coverage, measurements yield very similar rupture 
force distributions for G5-Ac70-FA2.7, G5-Ac70-FA4.7, and G5-Ac70-FA7.2.  In
examining forces obtained at high G5-Ac70-FAn coverage, we see that over half the force 
curves exhibit multiple PEG stretches, indicating multiple G5-Ac70-FAn binding events 
per pull.  Interestingly, the measured rupture forces for G5-Ac70-FA2.7, G5-Ac70-FA4.7,
and G5-Ac70-FA7.2 largely overlap, suggesting that an equal number of FAs per G5-Ac70-
FAn bind to the FBP surface per pull.  In other words, at this density coverage, increasing 
the number of FAs per G5 does not increase the average measured rupture force per 
single G5-Ac70-FAn.
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We have developed an incomplete hypothesis based on steric hindrance 
describing the difference in G5-Ac70-FAn-FBP interaction low and high density coverage.
At high density coverage, the G5-Ac70-FAn may be unable to bind optimally to the 
substrate surface.  This argument is based on the phenomena of prozone in which very 
high concentrations of antibody or antigen significantly inhibit immunological 
reactions.34   The result is that the binding that does occur is weaker than one would 
expect had the G5-Ac70-FAn been more isolated from other G5-Ac70-FAn as they would at 
low density coverage.  Still unresolved, however, is the discrepancy in the magnitude of 
the measured rupture forces obtained for the low and high density coverage G5-Ac70-FAn
data.  If the above analysis is correct, one would expect the measured rupture forces 
obtained at high density coverage to be lower in magnitude than those measured at the 
low density coverage.  However, this is not the case.  As noted in the results section, the 
average rupture force for the low density coverage data is significantly lower than that of 
the high density coverage data.
Although the low and high density coverage were obtained on the same 
instrument, the measurements for these two sets of data were taken months apart.  It 
should be noted that the high density G5-Ac70-FAn coverage data was obtained first and 
although we have no obvious reason to question the validity of this data, more familiarity 
with the technique during the acquisition of the low density G5-Ac70-FAn coverage data 
makes me as the experimentalist more trusting of this data.  In summary, no self-
consistent explanation for the low and high density data is apparent at this juncture.
Implications of the distribution forces seen under blocking conditions versus 
non-blocking conditions. The FBP substrate was incubated with free FA such that free 
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FA would block or reduce binding of the G5-Ac70-FA7.2 when it was brought into contact 
with the FBP substrate.  Although there was a decrease in frequency of binding, it is 
interesting to note that the average rupture force under blocking conditions is actually 
higher than under non-blocking conditions.  A hypothesis that has been put forth to 
explain this phenomena is that the lower rupture forces represent the binding of “few” 
FAs whereas the higher rupture forces represent the binding of “more” folic acids.  Under 
blocking conditions, the G5-Ac70-FA7.2 in question must compete with the free FA in 
order to bind to the receptor surface.  If “few” FAs per G5-Ac70-FA7.2 are optimally 
aligned with the receptor surface, one may bind but the free FA may then compete the 
G5-Ac70-FA7.2 off the FBP substrate during the 1 sec time scale of the pull.  However, if 
“more” G5-Ac70-FA7.2-bound FAs are aligned optimally and therefore bind to the 
receptor surface, these FAs would be less likely to be out competed by the free FA in 
solution (Figure 2.15).
These experiments must be repeated using more tips per G5-Ac70-FAn in 
order to obtain reliable data.   These experiments must be repeated in order to be sure 
that the distribution of forces obtained are representative of the G5-Ac70-FAn noted. 
Having only performed these studies using a single tip for each experimental condition, it 
does not appear possible to discuss the assignment of the forces in relation to the number 
of FAs present on the targeted nanodevice. One would need to adequately sample each 
solution of G5-Ac70-FAn to determine which rupture forces measured are, for example, 
associated with a true G5-Ac70-FA3 and which are associated with a G5-Ac70-FA1, G5-
Ac70-FA2, G5-Ac70-FA3, etc, all of which would be present in the G5-Ac70-FA3 solution.  
Requiring a Poisson distribution of FAs per G5-Ac70-FAn, we would need to perform 
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these studies on 11, 19 and 27 G5-Ac70-FAns per solution of G5-Ac70-FA3, G5-Ac70-FA5
and G5-Ac70-FA7, respectively to be 95% confident the average number of FAs on those 
particular G5-Ac70-FAns had an average of n ± 1 FAs.
Dynamic force microscopy would allow us to obtain absolute forces and 
evaluate aid us in our evaluation of the binding configurations of the G5-Ac70-FAn.
Looking at the force distribution obtained under low density conditions for the G5-Ac70-
FAn, we see two large distributions: one for G5-Ac70-FA2.7, and one for G5-Ac70-FA4.7
and G5-Ac70-FA7.2.  One could imagine assigning the entire force distribution of the G5-
Ac70-FA2.7 to the binding of 1 FA, 2 FAs, 3 FAs or a distribution of these three.  One 
could do a similar assignment to the rupture forces of G5-Ac70-FA4.7 and G5-Ac70-FA7.2,
and potentially determine the probability of binding for some number of FAs as a 
function of the number of FAs present on the G5-Ac70-FAn.  The studies presented here 
are performed at a single loading rate.  Therefore the rupture forces obtained in these 
studies are proportionally but not absolutely correct.  If one performed these same studies 
at a variety of loading rates for each conjugate, one could then plot the average rupture 
force (pN) vs. ln((loading rate)(pN/s)) and extrapolate out to a zero applied force to 
obtain the absolute force required to rupture the G5-Ac70-FA and FBP bonds.35-37
Ideally, one could also then obtain the force required to rupture a single FA-FBP bond 
either by synthesizing a G5-Ac70-FA1, or using the focal point of a dendron as a FA-
conjugation site thereby ensuring only a single FA is present.  If both the dynamic force 
and the single-FA measurements were obtained, one could determine the distribution of 
binding configurations of a G5-Ac70-FAn to the FBP receptor surface.
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2.5. CONCLUSIONS AND SUMMARY 
 We have shown that the rupture forces obtained from force pulling studies at low 
density coverage of G5-Ac70-FAn follow a similar trend to that seen in previously 
completed SPR and FACS studies.  The rupture forces obtained for a G5-Ac70-FA7.2 at 
low density coverage under free FA blocking conditions have a higher average rupture 
force than under non-blocking conditions.  At this time, it is not clear what the 
distributions of forces obtained from the high density coverage of G5-Ac70-FAn represent.   
 These studies must be repeated such that the distribution of G5-Ac70-FAn within a 
solution of G5-Ac70-FAn is adequately sampled.  In addition, dynamic force microscopy 
should be performed to obtained absolute rupture forces for each sample.  In doing this, 




Figure 2.1.  Dissociation constants (KD) obtained using SPR for a series of G5-FAn.  This data was 
obtained by S. Hong.   
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Figure 2.2.  Graph showing a linear increase in ka and exponential decrease in kd with increasing number 
of FAs, n.  This data was obtained by S. Hong and analyzed by P. Leroueil.   
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Figure 2.3.  The effect of the number of FAs, n, on G5-FAn binding as previously measured by surface 
plasmon resonance (SPR) and fluorescent activated cell sorting (FACS) (S. Hong).  Note that blue circles 
and red squares represent SPR and FACS results, respectively. The error bars represent standard deviations. 
The nanodevice with 2.6 FA shows a lower degree of cellular binding and association constant KA than the 
rest of the nanodevices. FACS data were obtained after incubation with dendritic nanodevices with FAR 
over-expressing KB cells at 37ºC and represent averaging from 12 different samples at each condition. 
Association constants were averaged values from at least three SPR measurements for each point. The 
association constant (KA =1/KD) is plotted in this case as it provides the best visual comparison to the 
FACS data. 27 (S. Hong) 
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Figure 2.4.  Depiction of experimental set-up.  A G5-FAn dendrimer is attached to an AFM tip (gold) via a 
PEG linker (tan).  Here, 7 FAs (red) are conjugated to the surface of the G5 dendrimer.   During force-
pulling measurements, the AFM tip is lowered, allowing the G5-FAn to interact with the FBP substrate 
surface.  The number of FAs per G5-FAn that bind to the FBP substrate is dependent on n. As the AFM tip 
is retracted, the FA-FBP bonds are ruptured.  This process is repeated until 2000 force-distance curves are 
obtained. (Art provided by Paul Trombley) 
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Figure 2.5.  Force (pN) vs. distance (nm) curves showing (a) specific G5-FAn binding to the FBP substrate 
and (b) specific G5-FAn and partial unbinding in the form of a ‘dislocation.’  Rupture forces were extracted 
from force-distance curves by determining the magnitude of (a) (d-c) and (b) (d-c) and (f-e).  Both (a) and
(b) were taken from curves obtained from G5-FA7 measurements. 
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Figure 2.6.  Histogram of rupture forces spanning 0-0.8 nN for G5-Ac70-FAn at low density G5-Ac70-FAn
coverage.  The maximum number of counted events occur at 0.68 (G5-Ac70-FA0), 0.08 (G5-Ac70-FA2.7), 
0.22 (G5-Ac70-FA4.7) and 0.21 nN (G5-Ac70-FA7.2).  Mean measured rupture forces are 0.66 (G5-Ac70-
FA0), 0.14 nN (G5-Ac70-FA2.7), 0.24 (G5-Ac70-FA4.7) and 0.23 nN (G5-Ac70-FA7.2).  Median measured 
rupture forces are 0.67 (G5-Ac70-FA0), 0.08 nN (G5-Ac70-FA2.7), 0.26 (G5-Ac70-FA4.7) and 0.23 nN (G5-
Ac70-FA7.2).  The median and means presented here are based on the 0-0.80 nN force region. 
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Figure 2.7.  Histogram of rupture forces spanning 0-0.96 nN for G5-Ac70-FAn at high density G5-Ac70-FAn
coverage.  The maximum number of counted events occur at 0.16 (G5-Ac70-FA2.7), 0.14 (G5-Ac70-FA4.7)
and 0.18 (G5-Ac70-FA7.2).  Mean measured rupture forces are 0.36 (G5-Ac70-FA2.7), 0.30 (G5-Ac70-FA4.7)
and 0.36 nN (G5-Ac70-FA7.2).  Median measured rupture forces are 0.29 (G5-Ac70-FA2.7), 0.24 (G5-Ac70-
FA4.7) and 0.30 nN (G5-Ac70-FA7.2). 
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Figure 2.8.  Histogram of rupture forces spanning 0-0.8 nN following incubation with free FA for G5-
Ac70-FA7.2 at low density coverage.  This is a 56% reduction in counted force events as compared to the 
measurement performed with no free folic acid present for the 0-08 nN region and a 63% reduction for the 
0-0.4 nN region.  For the 0-0.8 nN region, the average measured rupture force in the presence of 10μM free 
FA was 0.35 nN while the median rupture force was 0.31 nN for rupture forces.  For the 0-0.4 nN region, 
the average measured rupture force in the presence of 10μM free FA was 0.26 nN while the median rupture 
force was 0.26 nN. 
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Figure 2.9. Histogram of dislocations obtained for G5-Ac70-FAn at low density G5-Ac70-FAn coverage.  
The mean dislocation rupture force was 0.26 nN (G5-Ac70-FA2.7), 0.10 nN (G5-Ac70-FA4.7), and 0.14 nN 
(G5-Ac70-FA7.2). The median dislocation rupture force was 0.26 nN (G5-Ac70-FA2.7), 0.08 nN (G5-Ac70-
FA4.7), and 0.13 nN (G5-Ac70-FA7.2).  The median and means presented here are based on the 0-0.40 nN 
force region.   
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Figure 2.10. Histogram of dislocations obtained for G5-Ac70-FAn at high density G5-Ac70-FAn coverage.  
The mean dislocation rupture force was 0.35 nN (G5-Ac70-FA2.7), 0.22 nN (G5-Ac70-FA4.7), and 0.29 nN 
(G5-Ac70-FA7.2). The median dislocation rupture force was 0.28 nN (G5-Ac70-FA2.7), 0.18 nN (G5-Ac70-
FA4.7), and 0.24 nN (G5-Ac70-FA7.2).  The median and means presented here are based on the 0-0.96 nN 
force region. 
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Figure 2.11. Schematic distinguishing between high density G5-Ac70-FAn coverage and low density G5-
Ac70-FAn coverage.  Force-distance curves below each schematic serve as an experimental distinction 
between the two degrees of coverage.  Note that ‘high density’ coverage results in multiple PEG stretches 
whereas ‘low density’ coverage results in a single PEG stretch.   The length of each PEG stretch is 20-30 
nm which is consistent with what one would expect for a PEG (20 nm) + G5 PAMAM dendrimer (5-10 
nm).   
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Figure 2.12.  Histogram of rupture forces obtained for G5-Ac70-FAn at low density coverage spanning 
rupture forces from 0-0.40 nN.  Ruptures above 0.40 nN are believed not to be FA-FBP specific.  The mean 
rupture forces for G5-Ac70-FA2.7, G5-Ac70-FA4.7, G5-Ac70-FA7.2, and G5-Ac70-FA7.2 are 0.12, 0.22, 0.21 nN 
respectively.  The median rupture forces for G5-Ac70-FA2.7, G5-Ac70-FA4.7, G5-Ac70-FA7.2, and G5-Ac70-
FA7. are 0.10, 0.21, 0.21 nN respectively.   
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Figure 2.13.  Expected Poisson distribution of FAs on a dendrimer within a solution of G5-Ac70-FAn.  This 
analysis was based on the random addition of FA to the surface of the G5 dendrimer with 110 available 
conjugation points until there is an average of n FAs per G5-Ac70-FAn.   
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Figure 2.14 Schematic depicting the possibility that the saturation of binding seen in both the SPR and 
force pulling studies is due to steric inhibition  of the entire G5-Ac70-FAn once some number of FAs has 
bound.  Figure 2.14 shows that this inhibition occurs at 5 FA-FBP interactions but this number can be as 
low as 2 FA-FBP interactions.  Our data does not answer the question of the maximum number of FAs that 
bind to the FBP substrate under these conditions.
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Figure 2.15.  Schematic depicting hypothesis as to why the average rupture force between a G5-Ac70-FAn
and FBP substrate increases in the presence of free FA.  Note that the use of 1 and 2 FAs binding to the 
receptor surface is intended only to illustrate the idea of ‘more’ and ‘fewer’ FA-FBP bonds.  It is believed 
that the higher rupture forces represent ‘more’ FAs binding to the FBP substrate than the lower rupture 
forces.  Because of the difference in local concentration between those G5-Ac70-FAn that are binding via 
‘more’ FAs versus those that are binding with ‘fewer’ FAs, those bound via ‘more’ are more likely to 
displace the free FA bound to the FBP substrate.   
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THE INTERACTION OF POLYCATIONIC POLYMERS WITH SUPPORTED 
LIPID BILAYERS AND CELLS: NANOSCALE HOLE FORMATION AND 
ENHANCED MEMBRANE PERMEABILITY BY NON-TARGETED 
NANOPARTICLES 
3.1. BACKGROUND  
The previous chapter examined a particular type of targeted nanoparticle whose 
scaffold consisted of an acetylated PAMAM dendrimer.  Although our research group 
has had great success with this platform, it is by no means the sole candidate.   Several 
polycationic polymers have been employed in gene and drug delivery applications, 
including poly-L-lysine (PLL), polyethylenimine (PEI), diethylaminoethyl-dextran 
(DEAE-DEX), and non-acetylated PAMAM dendrimers.1-3  This chapter examines the 
interactions of these polycationic nanoparticles in their non-targeted form with cells and 
model membranes.
The generally accepted mechanism for internalization of polycationic polymers is 
through polycation-mediated endocytosis.4-7  The mechanism consists of the polycationic 
nanoparticle first binding to the outer cell membrane and subsequently internalized into 
the cell via endocytosis.  Once inside the cell, the nanoparticle is released from the 
endosome.  The electrostatic interactions between the polycationic polymer and the cell 
membrane is thought to play a critical role in the process.  Several research groups, 
including our own, have taken particular interest in the first step of the three-step process 
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of polycation-mediated endocytosis.  To address this, groups have used both model and 
cell membranes.  Studies involving model systems included incubation of polycationic 
nanoparticles such as PEI, PAMAM dendrimers and poly-(N-ethyl-4-vinylpyridinium 
bromide) with dye-containing vesicles.  Following incubation, it was found that the dye 
was released from the interior of the vesicle, signifying that disruption of the model 
membrane had occurred.8-10   In vitro studies have also demonstrated increased 
membrane permeability as determined by cytotoxicity (cytosolic enzyme leakage such as 
LDH) assays.11, 12   
We previously reported that the positively charged PAMAM dendrimers cause 
membrane disruption, allowing the diffusion of molecules in and out of cells.13  During 
the course of developing our targeted dendrimer-based platform, we noted that cells 
incubated with PAMAM dendrimers exhibited enzyme leakage while cells incubated 
with the acetylated form of the PAMAM dendrimer did not.  This in vitro result was 
consistent with the proposed hole formation mechanism, as suggested by atomic force 
microscopy (AFM) on a supported 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC) model membrane.14-17  There, it was shown that PAMAM dendrimers induce 
nanoscale defect formation in model membranes, while its acetylated forms aggregates, 
presumably within the model membrane.  Although this body of work suggests that 
internalization of polycationic nanoparticles occurs via membrane hole formation, no 
clear connection had been made between the proposed model and in vitro studies.16   
In this chapter, we correlate the formation of nanoscale holes using a series of 
common polycationic nanoparticles (PEI, PLL and DEAE-DEX) in model and real cell 
membranes.  It is hypothesized that these polycationic nanoparticles will (1) induce 
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nanoscale hole formation in supported lipid bilayers (SLBs) (2) cause substantial 
permeability of the cell membrane allowing enhanced enzyme and dye diffusion. In 
addition, it is hypothesized that (3) neutral, linear polymers (PEG, PVA) will not induce 
hole formation in SLBs or induce membrane permeability in cell membranes.  Within this 
chapter, AFM studies will demonstrate that nanoscale hole formation and/or expansion of 
pre-existing defects occurred in SLBs following incubation with the polycationic 
nanoparticles but not with the neutral linear polymers.  In vitro studies will show that 
only those cells incubated with the polycationic nanoparticles were made permeable to 
molecules such as enzymes (LDH, Luc), propidium iodide (PI), and FITC.  Interestingly, 
larger polycationic nanoparticles incubated with cells at low temperatures where the 
energy-dependent mechanism of endocytosis is thought to be inhibited have been shown 
to be still internalized, albeit to a less degree.13  These results directly support the three 
hypothesis described above and suggest that polycationic nanoparticles can enter the cell 
through a hole formation process and not simply through the traditionally accepted 
polycation-mediated endocytosis.  These studies have implications on the design and 
implementation of targeted delivery platforms.  
3.2. EXPERIMENTAL 
Materials and measurement of molar masses 
PLL, PLL-FITC conjugate (PLL-FITC), PEI, and DEAE-DEX were purchased 
from Sigma-Aldrich.  G5 PAMAM dendrimers were synthesized and then conjugated 
with FITC at the Michigan Nanotechnology Institute for Medicine and Biological 
Sciences, University of Michigan.13  DMPC lipids were provided by Avanti Lipids, 
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Alabaster, AL.  Chemical structures of the polycationic polymers used in this paper are 
illustrated in Figure 3.1. 
The molar mass moments and molar mass distribution of each polymer sample 
was measured using gel permeation chromatography (GPC).  The number average molar 
mass (Mn) and polydispersity index (PDI), a commonly used measure of the breadth of 
the molar mass distribution defined as the ratio of the weight and number average molar 
masses (Mw/Mn), of individual samples are listed in Table 3.1.  GPC experiments were 
performed using an Alliance Waters 2690 separation module (Waters Corp., Milford, 
MA) equipped with a Waters 2487 UV absorbance detector (Waters Corp.), a Wyatt 
Dawn DSP laser photometer (Wyatt Technology Corp., Santa Barbara, CA), an Optilab 
DSP interferometric refractometer (Wyatt Technology Corp.), and TosoHaas TSK-Gel 
Guard PHW 06762 (75×7.5 mm, 12 μm), G 2000 PW 05761 (300 × 7.5 mm, 10 μm), G 
3000 PW 05762 (300 × 7.5 mm, 10 μm), and G 4000 PW (300 × 7.5 mm, 17 μm) 
columns.  Column temperatures were maintained at 25 ± 0.2 °C with a Waters 
temperature control module.  Citric acid buffer (0.1 M) with 0.025 % sodium azide in 
water was used as a mobile phase.  The pH of the mobile phase was adjusted to 2.74 
using NaOH and the flow rate was maintained at 1 mL/min.  Sample concentration was 
approximately 2 mg/mL and an injection volume of 100 μL was used for all samples.  
Molar mass moments of the polymers were determined using Astra software (version 4.7) 
(Wyatt Technology Corp.).  Characterization of all polymers used here was completed by 
Mohammad T. Islam or Seungpyo Hong. 
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Preparation and AFM observation of supported DMPC lipid bilayers 
A 0.67 mg/mL suspension of small, unilamellar vesicles (SUVs) was prepared as 
previously reported 13, 14, 18.  Supported lipid bilayers were formed by depositing 80 L of 
liposome suspension on a 1×1 cm2 piece of freshly cleaved mica.  Following a 20 minute 
incubation period, the sample was gently rinsed with water to remove excess lipids and 
placed in the AFM for imaging as described in previous studies.  All AFM measurements 
were performed in tapping mode on a Nanoscope IIIa Multimode scanning probe 
microscope from Digital Instruments (DI, Veeco Metrology Group, Santa Barbara, CA).  
The AFM was equipped with a liquid cell (DI) and a silicone nitride cantilever (DI model 
NPS, spring constant 0.32 N/m, length 100 m) operating at a drive frequency of 6-9 kHz.  
After taking an initial image of the bilayer, approximately 20 L of polymer solution was 
injected into the liquid cell.  All solutions were prepared using high purity water (Nerl 
Diagnostics, East Providence, RI).  The temperature inside the liquid cell was 28 °C and 
therefore above the gel to liquid transition temperature of supported DMPC bilayers. 
Cell Lines 
The KB and Rat2 cell lines were purchased from the American Type Tissue 
Collection (ATCC, Manassas, VA) and grown continuously as a monolayer at 37 °C, and 
5% CO2 in RPMI 1640 medium (Mediatech, Herndon, VA) and Dulbecco’s modified 
Eagle’s medium (DMEM, Gibco, Eggenstein, Germany), respectively.  Rat2 cell line was 
transfected to permanently express the LUC gene using PAMAM dendrimer-mediated 
gene transfection as previously described.13, 19, 20  The LUC expressing Rat2 cells is noted 
as Rat2pLUC.  The RPMI 1640 and DMEM media were supplemented with penicillin 
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(100 units/mL), streptomycin (100 g/mL), and 10% heat-inactivated fetal bovine calf 
serum (FBS) before use.   
XTT, LUC, and LDH Assays and Flow Cytometry 
Cytotoxicity of the polycationic polymers was assessed with a 2,3-bis(2-methoxy-
4-nitro-5-sulfophenyl)-5[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay 
kit (Cell Proliferation Kit II, Roche Molecular Biochemicals, Mannheim, Germany).  KB 
and Rat2 cell lines (at a concentration of 5 × 104 cells/well) were prepared as monolayers 
in 96 well plates, followed by incubation with polymers in phosphate buffered saline 
(PBS) with Ca2+ and Mg2+ at 37 °C under 5% CO2 for 4.5 hrs.  Polymer solutions 
(supernatants) were removed and followed by washing with PBS twice.  Mitochondrial 
activities in the cells were then measured using the assay kit. 
The LDH and LUC activities in the cell supernatant after 3 hrs incubation were 
respectively analyzed using an LDH assay kit (Promega Co., Madison, WI) and a 
chemiluminescence assay(Promega Co., Madison, WI) as previously described.13  The 
measured LDH and LUC activities were either recalculated by percentage to the activities 
of cell lysates of intact cells (% LDH released) or adjusted for the protein concentration 
of the sample (relative light unit (RLU)/mg protein).  Flow cytometry was also performed 
according to our report.13  Fluorescence signal intensities were measured by a Coulter 
EPICS/XL MCL Beckman-Coulter flow cytometer and data were analyzed using Expo32 





A concentration of 2 × 104 cells/mL of Rat2 cells was seeded on MatTek glass 
bottom petri dishes (35 mm) and incubated at 37 °C under 5% CO2 for 24 hrs.  The 
DMEM media was removed and 2 mL of each PLL-FITC and dendrimer-FITC 
conjugates in PBS (Ca2+, Mg2+) solution was added into the appropriate dish.  The dishes 
were incubated with added solutions at 37 °C under 5% CO2 for 1 hr.  The conjugate-
containing solutions were removed and the resulting cell monolayer was washed with 
PBS.  Cells were fixed with 2% formaldehyde in the PBS (Ca2+, Mg2+) at room 
temperature for 10 min, followed by washing with PBS twice.  Confocal and differential 
interference contrast (DIC) images were taken on an Olympus FV-500 confocal 
microscope using a 40×, 1.2 NA oil immersion objective.  For the confocal images, the 
488 nm line of an argon ion laser was used for excitation and the emission was filtered at 
505 nm.  Note that all confocal images were obtained by Seungpyo Hong.   
3.3 RESULTS
Polycation-Induced Hole Formation on Aqueous Supported DMPC Lipid Bilayers 
The polycationic nanoparticles used in this study (PLL, PEI and DEAE-DEX) were all 
shown to disrupt DMPC supported lipid bilayers.  Several controls were performed for 
the AFM study.  Before the introduction (through injection) of polymers into the solution 
containing the aqueous supported lipid bilayers, the bilayers were imaged alone for 8 to 
10 minutes.  These pre-imaging steps were done to ensure that the bilayers were stable 
and that pre-existing defects that appeared were not due to the act of imaging itself.  A 
blank injection of water (the solvent in which the polymers were dissolved) was 
completed and resulted in no change to the bilayer over the course of a normal imaging 
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session (60 to 90 minutes).  This shows that the injection itself is not responsible for the 
formation of defects.  Finally, injections of 1 μg/mL of polyethylene glycol (PEG) and 
polyvinyl alcohol (PVA), two neutral polymers, were performed and resulted in no 
change to the supported bilayers over normal imaging time.
Images taken using AFM show that PEI, PLL and DEAE-DEX all disrupt DMPC 
supported lipid bilayers.  Figures 3.2, 3.3, and 3.4 are representative data sets of the 
polycationic polymers and DMPC lipid bilayer interactions.  Although there is some 
variation, several repetitions were completed for each polymer confirming that the 
degrees of membrane/polymer interactions are qualitatively similar.  Following the 
addition through injection of PLL into the AFM liquid cell at a final concentration of ~ 1 
ug/mL (Figure 3.2), new defects in the bilayer are formed.  The depth of these defects in 
the membrane is primarily in the range of 4.0-4.8 nm.  Addition of PEI onto the bilayer, 
however, results in mostly the expansion of pre-existing defects (Figure 3.3).  These 
expanded defects have measured 4.4 to 5.1 nm in depth which is consistent with the 
removal of a full bilayer.  Interestingly, the introduction of DEAE-DEX to supported 
DMPC bilayers results in only 2 to 4 nm deep depressions.    
Cytotoxicity of Polycation and Polycation-Induced Enzyme Leakage 
The cytotoxicity of the polymers was determined using an XTT assay (Figure 
3.5). The relative cell viability was calculated as: 
[OD492nm]sample/[OD492nm]control × 100. 
The assay results show that the polymers are not cytotoxic up to a 12 g/mL 
concentration (> 80% cell viability) for both KB and Rat2 cells.  Based on these data, the 
assays performed to investigate the cytosolic enzyme release were carried out in polymer 
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concentrations of 6 and 12 g/mL.  Within this range, the polymers are non-cytotoxic so 
the observed enzyme release can be ascribed to an increase in cell membrane 
permeability as opposed to general lysis due to cell death. 
The effect of positively charged polymers on the cell membranes was investigated 
in terms of cytosolic enzyme release from the cells using LDH and LUC assay techniques.  
As the polymer concentration increases, the amounts of both LDH and LUC released 
increased as illustrated in Figure 3.6 and 3.7.  Induced membrane permeability as 
measured by LDH release shows a degree of cell type (KB and Rat2) dependence as 
shown in Figure 6.  In both cell types (Figure 6), however, PEI induced more LDH 
leakage as compared to the other polycationic polymers.  This is not surprising because 
PEI possesses a much greater charge/monomer ratio (see Table 3.1) as compared to the 
other polymers.  G5-NH2 and PLL cause similar amount of LDH release and the least 
LDH was released from the cells after exposure to DEAE-DEX among the polycationic 
polymers, particularly in the case of the Rat2 cells.  PEG and PVA did not cause enzyme 
leakage.  LUC release from Rat2pLUC exhibits a trend similar to the LDH release from 
cells seen as discussed above (Figure 3.7). 
Binding and Internalization of PLL-FITC 
PLL-FITC conjugate was used for direct observation by CLSM.  This experiment 
was carried out to compare the internalization behavior of PEI, PLL, and DEAE-DEX 
polymers to that of dendrimeric G5-NH2.  Figure 3.8 shows that PLL-FITC is 
internalized into the Rat2 cells resulting in strong fluorescence of FITC from inside the 
cells.  In particular, the intracellular location of the internalized conjugates appears to 
exclude the nucleus.  This internalization behavior is particularly interesting because 
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penetration of the polymers into the nucleus should be avoided for non-toxic gene 
delivery as it may alter the DNA sequence.  G5-Ac-FITC, which remains neutral in water 
due to the conversion of all the surface primary amines groups to acetamide groups, is not 
internalized as shown in Figure 3.8e allowing the conjugate to be used as a negative 
control.13  The DIC image is provided to show that an appropriate cell density was used 
(Figure 3.8f).  
Diffusion of Small Molecules through the Permeabilized Membranes. 
It is known that PI and FDA can be employed as indicators of diffusion-in and out, 
respectively.13, 21  PI is readily internalized into cells with disrupted membranes but is 
excluded from cells with intact membranes.  In contrast, FDA is able to traverse intact 
membranes and is then converted to fluorescein (FITC) by endogenous esterase in cells.  
The resulting FITC is unable to travel across intact membranes but is able to traverse 
permeabilized membrane.  Therefore, it is assumed that PI fluorescence should increase 
and FITC fluorescence should decrease with increasing membrane permeability.  Figure 
9a shows the increase in PI signal intensity induced following the incubation of KB cells 
with the polycationic polymers.  The greatest PI intensity increase is seen using PEI, 
followed by G5, DEAE-DEX, and PLL. Charge neutral PVA and PEG do not induce PI 
internalization. On the other hand, FITC fluorescence intensities are decreased after 
exposure to the polycationic polymers in a concentration-dependent manner (Figure
3.9b).  The largest amount of intensity drop is observed in the PEI case, although DEAE-
DEX, PLL, and G5 also show a decrease in FITC fluorescence intensity.  As expected, 




Evidence for Hole Formation by Polycationic Polymers PEI, PLL, and DEAE-DEX 
We previously reported nanoscale hole formation on both supported lipid bilayers 
and cellular membranes induced by positively charged PAMAM dendrimers 13-17.  In this 
study we test the possibility of extending the proposed mechanism of 
dendrimer/membrane interactions, i.e. hole formation by sphere-like PAMAM 
dendrimers, to the more common and inexpensive polycationic polymers PEI, PLL, and 
DEAE-DEX.  Polycationic polymer-induced disruption of various supported 
phospholipid bilayers including dioleoyl phosphatidyl choline (DOPC), dioleoyl 
phosphatidyl serine (DOPS), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidic acid 
(POPA), and their mixtures has been reported using various methods.  These techniques 
include quartz crystal microbalance with dissipation, leakage assay, 31P NMR, and 
electrophoretic mobility.9, 10, 22  Furthermore, polycationic polymer-induced 
permeabilization of living cell membranes has also been observed in vitro using enzyme 
assays and flow cytometry.11, 13  In this paper, we correlate two separate types of studies 
(model membrane and in vitro studies) by performing simultaneous experiments at 
similar conditions to provide a better understanding of polymer/membrane interactions.   
There are two basic types of disruption seen in AFM images: membrane hole 
formation and membrane thinning.  ‘Membrane hole formation’ is the complete removal 
of the lipid bilayer from the mica surface, resulting in defects of 4 to 5 nm in depth.  The 
apparent discrepancy between the expected depth for a removal of a full bilayer, 5 nm, 
and the depths experimentally measured in this study can be explained by the varying 
degrees of polymer adsorption to the surface of the mica.   ‘Membrane thinning,’ which 
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could result from the re-orientation of lipids or the removal of a layer of lipid from the 
lipid bilayer, yields depressions ranging between approximately 2 and 3 nm.23-26  
Although the effect of each of the polymers used in the study varies in degree, 
each of these commercial polycationic polymers induce disruption of the bilayers as 
shown in the AFM images (Figures 3.2-3.4). This study is consistent in terms of 
observing bilayer disruption but differs in both the type of disruption and concentration 
dependence as compared with the previous studies which examined the interaction of 
positively charged dendrimers with a DMPC supported lipid bilayers.14  Our in vitro 
study shows enzyme (LDH with MW 135-140 kDa and ~4.3 nm in radius and LUC with 
MW 61 kDa and ~2.7 nm in radius) leakage out of the cells, polymer internalization into 
the cells, and diffusion in and out of small molecular probes (PI and FITC respectively) 
through the living cell membranes (Figure 3.6-3.9) which are also consistent with our 
previous report using cationic PAMAM dendrimers.13  Therefore, it is clear that PEI, PLL, 
and DEAE-DEX also cause the formation of defects in both supported lipid bilayers and 
cell membranes. 
Relationship between Polymer Properties and Membrane Permeabilization 
As modern biotechnology tends towards the adaptation of biocompatible 
polymers for advanced biomedical applications, a fundamental understanding of these 
polymers, particularly in physiological conditions, should be obtained.  In this paper, we 
try to provide a better understanding of the relationship between physical properties of 
polymers and biological membranes.  GPC measurement enables us to rank 
hydrodynamic radii of the polycationic polymers in the following order: DEAE-DEX > 
PEI > PLL > G5 PAMAM.  According to our AFM and in vitro studies, however, the 
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size of the polymers does not seem to markedly affect their ability to induce hole 
formation in the membranes.  Instead, it was found that the degree of membrane 
permeability for the flexible polycationic polymers investigated here is strongly 
dependent on the number of formal charges on the polymer chain.  As shown in Table 
3.1, PEI has the greatest density of charged groups on its single polymeric chain among 
the polymers used in this study.  Not surprisingly, a significantly high amount of LDH 
and LUC was released in both cell lines after incubation with PEI.  Furthermore, changes 
in fluorescence in PI and FITC, as a result of interactions between PEI and cells, were 
greater than changes induced by the other polycationic polymers.  This indicates that 
charge interactions play a key role in inducing changes of membrane permeability, i.e. 
nanoscale hole formation.  Our data on PLL, DEAE-DEX, and G5-NH2, however, 
suggests that electrostatic interactions are not the only factor contributing to the 
effectiveness of polymer-induced nanoporation.  Although PLL has an order of 
magnitude higher charge/monomer ratio than DEAE-DEX and G5-NH2, the difference 
among those polymers in terms of enzyme leakage, PI internalization, and FITC escape is 
not remarkable.  One possible explanation is that efficacy of hole formation is dependent 
on the architecture of polymers.  That is, sphere-like (PAMAM), branched (PEI), or ring-
containing (DEAE-DEX) molecular structures are likely more effective than linear 
polymers (PLL) at increasing membrane permeability.  Mecke et al. also suggested that 
the macromolecular architecture is an important factor in the polymer/membrane 
interactions.14   
In summary, Chapter 3 confirms our hypotheses that three commonly used 
polycationic nanoparticles (PEI, PLL and DEAE-DEX) (1) induce nanoscale hole 
60 
 
formation in supported lipid bilayers (SLBs) (2) cause substantial permeability of the cell 
membrane allowing enhanced enzyme and dye diffusion.  In addition, we found that two 
neutral linear polymers, PEG and PVA, did not induce nanoscale hole formation in SLBs, 
or cause substantial permeability in cell membranes.   
The conclusions we draw from these studies are two-fold.  First, from a 
mechanistic standpoint, these linear polycationic polymers interact in a similar fashion to 
the spherical PAMAM dendrimer when exposed to model and real membranes.  
Although we had hypothesized this to be the case because of their similarity in their 
chemical make-up, it was not clear that the spherical shape of the dendrimer was not 
critical for hole formation within the membrane.   Chapter 4 will go into further detail 
regarding additional nanoparticle properties that mediate hole formation within 
membranes.  
Second, from an application standpoint, these studies suggest that polycationic 
polymers are inappropriate as scaffolds for targeted delivery platforms.  Indeed, the non-
specific interactions these polycationic nanoparticles have with cell membranes would 
likely overwhelm any ‘targeting’ one could achieve using a targeting moiety.  We have 
previously shown with our own targeted platform system that non-specific interactions 
dominate the nanoparticle-cell interactions when not fully acetylated following 
functionalization (unpublished work by Thommey Thomas, MNiMBS). In principle, one 
could similarly functionalize the other polycationic nanoparticles presented here and then 
acetylate their remaining amines to form a targeted platform.  In practice, however, the 
ill-defined structures of PLL, PEI and DEAE-DEX as compared to that of the PAMAM 





impossible.  Given the clear importance of controlled functionalization, particularly in the 
case of targeted drug delivery platforms, these non-homogenous linear polycationic  




Figure 3.1.  The structures of the linear polycationic nanoparticles 
used within these studies.   




Figure 3.2 AFM images of supported DMPC lipid bilayers upon exposure to poly-L-lysine
(PLL).  20 L of 10 g/ml PLL injected following image a), resulting in a final concentration of
~1.0 g/ml in the AFM liquid cell.  Total time between a) and c) is approximately 50 minutes.
Several dotted white circles indicate formation of new holes in the lipid bilayers caused by PLL.
Bar: 500 nm.  Z-scale: 20 nm. 
Figure 3.3 AFM images of supported DMPC lipid bilayers upon exposure to poly(ethylenimine)
(PEI).  20 L of 5g/mL PEI injected following image a) resulting in a final concentration of
~0.5 g/mL.  An additional 20 L of 10 g/mL was injected after b), resulting in a final
concentration of ~1.5 g/mL.  Total time between a) and c) is approximately 40 minutes.  Note
that there is no new hole formation but instead the pre-existing defects are expanded (see white
arrows).  Bar: 500 nm.  Z-scale: 20 nm. 
Figure 3.4 AFM images of supported DMPC lipid bilayers upon exposure to diethylaminoethyl-
dextran (DEAE-DEX).  50 L of 5 g/mL DEAE-DEX injected following image a), resulting in
a final concentration of ~1.3 g/mL.  Total time between a) and c) is approximately 90 minutes.
Unlike that PLL and PEI create or expand defects in the lipid bilayers, DEAE-DEX induces
membrane thinning.  The newly formed defects are 2-4 nm deep instead of complete removal of
the lipid bilayers (~4-5 nm deep).  Bar: 500 nm.  Z-scale: 20 nm.  Elizabeth Janus is
acknowledged for her help in obtaining these images.
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Figure 3.5 Cell viability determined by XTT assay of a) KB and b) Rat2 cells after incubation with
PLL, PEI, DEAE-DEX, and G5-NH2 PAMAM at 37 °C for 4.5 hrs.  Note that all the polymers are
not cytotoxic up to a concentration of 12 g/mL  Note that this data was obtained by S. Hong.
Figure 3.6 Dose-dependent LDH release from a) KB and b) Rat2 cell lines incubated with PLL, PEI,
DEAE-DEX, G5-NH2 PAMAM, PEG, and PVA at 37 °C for 3 hrs.  All the polycationic polymers
induce LDH leakage but the neutral polymers PEG and PVA do not cause any significant leakage.
Note that these studies were completed by Seungpyo Hong.
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Figure 3.7 Dose-dependent luciferase (LUC) release from Rat2pLUC cell line incubated with PLL, PEI, DEAE-
DEX, G5-NH2 PAMAM, PEG, and PVA at 37 °C for 3 hrs.  Before the incubation, Rat2 cells were transfected by
PAMAM dedrimer-mediated cell transfection to express LUC in their cytosols.  As seen in the LDH assay data in
Figure 6, all the polycationic polymers used in this study also cause LUC leakage but the neutral polymers do not.
Note that these studies were completed by Seungpyo Hong. 
Figure 3.8. Confocal microscopy images of Rat2 cells incubated with a) 6 μg/ml PLL-FITC and b) 12 μg/ml
PLL-FITC conjugates.  c) A zoomed-out image of b).  Rat2 cells incubated with d) 6 μg/ml G5-NH2-FITC and e)
12 μg/ml G5-Ac-FITC conjugates.  f) Differential interference contrast (DIC) image of e), shown to illustrate that
there are a decent amount of the cells at the focal plane although nothing can be seen in the fluorescence image e).
Note that the green fluorescence from either PLL-FITC or G5-NH2-FITC does not occur from within cell nuclei
which are indicated by several dotted white circles.  The location of the nuclei and the exclusion of the
polycationic polymers were confirmed in previously published work using DAPI staining of the nucleus (15).
Note that these studies were completed by Seungpyo Hong. 
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Figure 3.9. Fluorescence intensity of a) propidium iodide (PI)
and b) fluorescein (FITC) from KB cells measured by flow
cytometer.  Note that fluorescence intensity of PI should increase
while that of FITC should decrease with increase of membrane
permeability.  All the polycationic polymers cause an increase of
PI fluorescence intensities and a decrease of FITC fluorescence.
However the neutral polymers do not cause such changes.  Note
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EXAMINING THE INTERACTION OF A VARIETY OF COVALENTLY-
LINKED CATIONIC NANOPARTICLES WITH SUPPORTED LIPID BILAYERS 
USING AFM
4.1. BACKGROUND 
Nanoparticles are currently employed or proposed for a variety of products 
including drug and gene delivery materials,1, 2 industrial applications such as catalysts,3
and consumer products including paints4 and lotions.5  Although the technical benefits of 
using nanoparticles for each particular implementation are clear; the broader impacts of 
the release of such materials into the environment have yet to be understood.6-8 One 
concern is the cytotoxicity of these materials.  An interaction of particular interest is that 
between the cell plasma membrane and nanoparticles, as this is the basic structure of the 
cell that may be breached with concomitant cytotoxicity.  
A great deal of empirical evidence suggests that nanoparticles are effective 
disruptors of cell plasma membranes.  Ready access to this work is provided by a number 
of recently published papers demonstrating both in vitro,9-13 as well as in vivo13-18
nanoparticle activity with membranes.  Specifically, cell level data have demonstrated 
evidence for membrane permeability via enzyme leakage assays7, 10, 12, 19 and dye 
diffusion studies.12  Direct evidence that the nanoparticles disrupt lipid bilayers was 
provided by electron paramagnetic resonance (EPR).20, 21  Studies on supported lipid 
bilayers (SLBs) have identified two general types of disruption:  (1) nanoscale hole 
formation and (2) membrane thinning.  These mechanisms have been explored using 
oriented circular dichroism (OCD),22, 23 X-ray diffraction,22 solid state NMR,24 molecular 
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modeling,10, 25, 26 and atomic force microscopy (AFM).10, 12, 23-25, 27, 28  The AFM/SLB 
assay has proven to be a particularly powerful tool for studying this problem because it 
provides images of the disruption events on the nanometer scale.  This assay is completed 
by first depositing a drop of 1 mg/mL lipid vesicle solution on a cleaved mica surface.  
Following an incubation time of approximately 20 minutes, excess lipid is removed by 
gently rinsing the newly formed SLB with water.  After a stable image of the SLB using 
tapping/AC mode AFM is obtained, nanoparticles are introduced and imaging continues 
until the SLB is once again stable.  An interesting example of the AFM/SLB assay used 
MSI-78 as the nanoparticle and demonstrated that localized ~1 nm diameter membrane 
thinning events occurred, as opposed to a continuous even thinning over the entire 
membrane.23  In contrast, previous experiments implementing dye diffusion enzyme 
leakage assays or membrane curvature experiments were also not able to provide 
nanoscale mechanistic information.  Recent AFM experiments performed in parallel with 
dye diffusion and enzyme leakage assays have provided direct evidence of the formation 
of nanoscale holes in SLBs and provided a common mechanism that is consistent with all 
three of the previous experimental observations.10, 12
We have previously shown that the degree of SLB disruption caused by  polymer 
nanoparticles  (e.g., hole formation, membrane thinning), correlates with the level of 
enzyme leakage, dye diffusion, cytotoxicity, and nanoparticle uptake measured in vitro 
(this AFM data is shown in Figures 4.3b-d and 4).10, 12, 27  In addition, the degree of 
membrane disruption parallels the degree of non-selective tissue uptake observed in
vivo.29  This correlation between the AFM/SLB assays and the in vitro and in vivo studies 
inspired us to examine the disruption between other nanoparticles that are well-
precedented to disrupt and/or translocate across cell membranes.  We therefore chose the 
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AFM/SLB assay to explore the behavior of a number of other important materials 
including a pentanol-core G3 dendron, the cell penetrating peptide MSI-78,30 the TAT 
sequence31 employed by HIV virus, amine-coated gold nanoparticles,19, 32 and amine-
terminated silica.33, 34 This set of particles, when combined with our previous studies on 
G3, G5, and G7 PAMAM dendrimers,10 polyethyleneimine (PEI) and diethylaminoethyl-
dextran (DEAE-DEX)12, presents a wide range of physical properties (organic vs. 
inorganic; small vs. large; flexible vs. rigid; spherical vs. irregular) that may affect the 
degree of membrane disruption.    
4.2 EXPERIMENTAL 
Liposome preparation
1,2-dimyristoyl-sn-glycero-3-phosphocholine was purchased from Avanti Lipids, 
Alabaster, AL. A 2 mg/ml suspension of small, unilamellar vesicles (SUVs) was prepared 
as follows.  Fourteen (14) mg of the powdered DMPC was dissolved in approximately 1 
mL of chloroform inside a 10 ml round bottom flask. The solvent was then evaporated 
using a rotary evaporator to form a thin lipid film. This film was hydrated by adding 0.1 
M NaCl solution followed by shaking and sonication until the lipids were completely 
dissolved. The resulting large, multilamellar vesicles (LMVs) were broken down to 
SUVs by using a probe sonicator.  The resulting suspension was placed in a bench-top 
centrifuge and spun at full speed for 20 minutes.  The supernatant was removed and 
placed in another 2.5 mL glass vial.  The resulting clear suspension was diluted further 
with 0.1 M NaCl solution to obtain a final lipid concentration of 2 mg/mL. Lipids 
solutions were further diluted with 0.1 NaCl as needed.  All water used in the 
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experiments was ultrapure (type I) water.  SUVs were used within one week of 
fabrication.
Sample Preparation 
A drop of 1 mg/mL DMPC liposome suspension was placed on a l cm× l cm piece 
of freshly cleaved mica attached to a metal sample puck by double sided tape. After an 
incubation time of about 20 min, excess lipids were removed by gently rinsing with 
water.  It is critical that the bilayer remain hydrated at all times.  The sample was placed 
in the AFM and imaged under a water drop to confirm that a bilayer had formed and 
remained unchanged between subsequent images.  Note that images were obtained in 
either tapping or AC mode.  Nanoparticles were then introduced via a syringe onto the 
surface of the substrate.  The volume introduced per injection was 20 μL.  Subsequent 
images were captured showing the progression of the nanoparticles’ effect on the model 
membrane. 
Images were obtained using Veeco MultiMode IIIA and PicoPlus Molecular 
Imaging AFMs and were done so using their respective liquid cells and a syringe.  
Images were obtained in tapping and AC mode, respectively.  Concentrations of 
nanoparticles are estimated based on volume of nanoparticles introduced to the liquid cell 
divided by the total volume of the appropriate liquid cell.  Note that both mass and molar 
concentrations are given where appropriate for ease of comparison between particles.   






















MSI-78 9 2,640 1.1 15 0.6 
Defect Eroder 
TAT  50 33,000 2.5 79 0.6 
Defect Inducer 
PAMAM G3-NH2 32 69 1.6 32 1
Surface 
Aggregator 
PAMAM G5-NH2 128 28,000 2.3 64 2. 
Defect Eroder 
PAMAM G7-NH2 512 117,000 3.6 162 3. 
Defect Inducer 
G3-NH2 Dendron 16 3,642 1 13 1.2 
Defect 
Aggregator 
PEI 14 78,220 3 110 0.1 
Defect Inducer 
DEAE-DEX 0.1 18,000 2 50 2 x 10-3
Defect Inducer 
Au-NH2 80 87,800 2 50 1.5  
Defect Eroder 
Silica-NH2 13,000 104,000,000 25 7,854 2
Defect Inducer 
Table 4.1. Physical properties of nanoparticles used in this study.
MSI-78 (natural, net-positively charged protein) 
MSI-78 (1a), a 22 amino acid protein with 9 of those residues positively charged at pH 
7.2 was obtained from A. Ramamoorthy’s Research Group (Department of Chemistry, 
University of Michigan) and dissolved in Millipore water.  Approximately 20 uL of 30 
mg/mL MSI-78 was injected onto a DMPC supported lipid bilayer (1b) yielding a final 
concentration of 1.2 mg/mL (450 nM) MSI-78.  Subsequent images were (1c-1d) were 
taken over a period of 40 minutes.   
TAT (natural, net positively charged protein) 
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TAT (2a), a 275 amino acid protein with 50 of those residues positively charged at pH 
7.2, was obtained from C. Fierke’s Research Group (Department of Chemistry, 
University of Michigan) and dissolved in Millipore water.  Approximately 150 uL of 500 
nM TAT protein was injected onto a DMPC supported lipid bilayer (2b) yielding a final 
concentration of ~300 nM TAT (10 ug/mL) TAT.  Subsequent images (2c-2d) were taken 
over a period of 25 minutes. 
PAMAM Dendrimers (flexible spherical synthetic polycationic polymer)
 PAMAM dendrimers were purchased from Dendritech then purified and 
characterized by the Michigan Nanotechnology Institute for Medicine and Biological 
Sciences at the University of Michigan (Ann Arbor, MI) and dissolved in Millipore 
water.   Approximated 25 nM of G3-NH2(32) (3a), G5-NH2(128) (3b), and G7-NH2(256)
(3c), were introduced to supported DMPC bilayers.  This corresponds to 0.1 ug/mL (G3-
NH2), 0.7 ug/mL (G5-NH2) and 3.0 ug/mL (G7-NH2).  Approximately 500 nM of 
pentanol core-based G3-NH2(16) (3d) were introduced to supported DMPC bilayer.  This 
corresponds to 0.04 ug/mL G3-NH2 dendron. Subsequent images were taken over a 
period of 30-60 minutes. Note that the number of amines per PAMAM dendrimer is 
based on theoretical values.
PEI (irregular synthetic polycationic polymer) 
PEI was purchased from Sigma Aldrich and dissolved in millipore water without any 
further purification.  Approximately 20 uL of 1 ug/mL PEI (Mn: 78,220, PDI: 3.44) was 
injected onto a DMPC supported lipid bilayer (3a) yielding a final concentration of ~ 1 
μg/mL PEI.  Subsequent images (1c-1d) were taken over a period of 40 minutes. 
76
DEAE-DEX (irregular synthetic polycationic polymer) 
DEAE-DEX (2a) was purchased from Sigma Aldrich and dissolved in Millipore water 
without any further purification.  Approximately 20 μL of 1 ug/mL DEAE-DEX (Mn: 
18,490; PDI: 32.90) was injected onto a DMPC supported lipid (2b) bilayer yielding a 
final concentration of ~1 μg/mL DEAE-DEX.  Subsequent images (2c-2d) were taken 
over a period of 90 minutes. 
Au-NH2 (small rigid inorganic sphere, surface modified with positive charges)
Au-NH2 nanoparticles (5a) consisting of ~2 nm gold cores surface-modified with ~80 
alkyl amines per particle (determined using potentiometric titration) yielding a final 
diameter of ~ 5 nm, were fabricated via standard procedure19 by V. Rotello’s research 
group and dissolved in Millipore water.  Approximately 40 μL of 2.5 μM Au-NH2 were 
injected onto a DMPC supported bilayer (5b) yielding a final concentration of 500 nM 
(44 μg/mL) Au-NH2 nanoparticles.  Subsequent images (5c-5d) were taken over a period 
of 30 minutes. 
Si-NH2 (large rigid inorganic sphere, surface modified with positive charges)  
Si-NH2 nanoparticles (6b) consisting of ~50 nm silica modified with ~13,000 amino 
groups (determined using potentiometric titration) with were obtained from G. Kisker 
GbR (Frankfurt, Germany) and dissolved in Millipore water.   Approximately 60 uL of 
10 mg/mL were injected onto a DMPC supported bilayer (6b) yielding a final 
concentration of 3 mg/mL (30 nM) Si-NH2 nanoparticles.  Subsequent images (6c-6d) 
were taken over a period of 45 minutes.   
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4.3 RESULTS AND DISCUSSION 
Many small biological nanomaterials found in nature are capable of traversing cell 
membranes.  Examples  include MSI-7835 and TAT.36 The ability to penetrate cell 
membranes is not only advantageous for the host and virus, respectively, but potentially 
also a useful tool for scientists seeking to utilize these natural transportation systems for 
cellular delivery.  The interaction between MSI-78 and the SLB was found to be 
concentration-dependent.  At lower concentrations (~2 μg/mL), non-uniform membrane 
thinning of SLBs is observed.24  At higher MSI-78 concentrations (1.2 mg/mL), the 
erosion of pre-existing holes in the lipid bilayer is found. (Figure 4.1)  TAT, a larger 
protein in comparison to MSI-78, induces the formation of holes in the bilayer (Figure 
4.2) at significantly lower concentrations than was required for MSI-78.  These SLB 
studies are consistent with cell level studies that have shown both of these biological 
proteins are internalized,36 and more indirectly, are capable of disrupting cell 
membranes.9-12
A variety of polymers have been used to mimic the ability of natural particles to 
breech cellular membranes.  PAMAM dendrimers are highly charged spherical polymers 
that have been employed as transfection agents in drug delivery.2, 12, 37, 38  Earlier studies 
by our group showed that the positively charged polymers interact with the supported 
lipid bilayer in a generation-defined dependent fashion.25, 27 That is, G3-NH2 dendrimers 
(32e+) accumulate around the edges of pre-existing defects, while the more highly 
charged G5-NH2 (128e+) and G7-NH2 (512e+) expand pre-existing defects and form new 
defects, respectively (Figure 4.3b-d).  In order to consider a change in topology while 
keeping a constant chemical composition, we now present the results for pentanol-core 
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G3-NH2 dendrons (16e+) (Figure 4.3a).   The number of positive charges listed represent 
the theoretical number of amine terminal groups on each dendrimers, with all amine 
groups expected to be protonated.under the conditions employed39, 40 Following addition 
to the SLB, G3-NH2 dendrons were shown to both accumulate around the edges of pre-
existing defects, as well as expand those defects.  Two commonly utilized linear 
polycationic polymers, PEI and DEAE-DEX, have also previously been shown to induce 
the formation of nanoscale defects within the model membrane (Figure 4.4).12  In these 
cases, however, no polymer accumulation around SLB defects was witnessed.   
Given the wide range of rigid nanoparticles currently in use, two inorganic 
nanoparticles, Au-NH2 and silica-NH2, were selected for testing.  Gold nanoparticles are 
perhaps the most well studied class of nanoparticles, and like dendrimers, have been 
utilized as transfection agents.32  The versatility of gold nanoparticles both in their 
tunable size and functionality make them a convenient choice in examining the effect 
rigidity has on nanoparticle-membrane interaction.  Experiments using 2 nm gold 
nanoparticles coated with an alkylamine substituent (total diameter: ~5-6 nm) show that 
supported lipid bilayers were disrupted primarily by expanding pre-existing defects.  This 
is reminiscent of what was seen in the case of G5-NH2..  Initially upon lipid erosion, the 
underlying mica surface is clean.  However, after 6 min the Au-NH2 nanoparticles, 
possibly aggregated with lipid, are observed to aggregate on the negatively charged mica. 
PEI and PAMAM dendrimers have also been observed to bind to the mica surface.10, 12
These Au-NH2-SLB interactions suggest that rigid-inorganic cores do not alter the gross 
nanoparticle-membrane interaction seen with the other classes of nanoparticles.   
Although biology and thus nano-medicine primarily focuses on the 1-15 nm scale, 
the 50 nm size of the silica-NH2 particles remain pertinent given industrial uses of 
79
particles in this size range.  Given the rigid inorganic core and amine-terminated surface, 
silica-NH2 particles provide an example which is both significantly larger and does not 
contain a flexible, organic core.  Despite these differences, the silica-NH2 nanoparticles 
induced the formation of holes following addition to the supported lipid bilayer (Figure 
4.6).  This is similar to what was seen in the G7-NH2 case.
Taking a broad view of these interactions, we note that the nanoparticles we 
studied can be divided into three subcategories: 1) particles that aggregate around defects 
and on the lipid bilayer surface (pentanol-core G3-NH2 dendron, PAMAM G3-NH2,) but 
are not effective at inducing defects 2) particles that encounter the surface, do not directly 
induce defects, but instead diffuse to existing and expand them (Au-NH2, MSI-78, 
PAMAM G5-NH2,) and 3) and particles that are capable of directly inducing defects in 
lipid bilayers (TAT, PAMAM G7-NH2, PEI, DEAE-DEX and silica-NH2).  Based on 
these studies, cationic nanoparticles with quite different sizes, shapes and flexibility are 
all capable of disrupting SLBs in the nanomolar range.   
When making qualitative comparisons between these particles, one must recall 
that the concentrations used for the imaging experiments differ so as to focus on the 
concentration range where the particles disrupt the bilayer.  Keeping this in mind, we 
note that cationic charge density does not serve as a good predictor of the interaction 
across nanoparticle classes.  However, the surface area of the cationic nanoparticle does 
roughly correlate with the degree of nanoparticle-lipid interaction.   Those particles that 
have greater surface areas (> ~60 nm2) are generally more effective at inducing SLB 
disruption than those with smaller surface area (< ~60 nm2), while these latter particles 
were more likely to aggregate on the surface around pre-existing defects.   
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The results presented within this paper are consistent with several studies 
previously performed by other groups.  A thermodynamic model describing the 
mechanism of interaction between PAMAM dendrimers, and more generally 
nanoparticles, and lipid bilayers has recently been completed by Ginzburg and 
Balijepalli.41  Within the model it shown that charged nanoparticles with diameters 
comparable to that of a lipid bilayer show an increased tendencies to induce defect 
formation within lipid bilayers.   Our results, as well as those of Ginzburg and Balijepalli, 
are also consistent with the observations of Oberdorster et al. who demonstrated that 
ultrafine particles (diameter ~20 nm ) induce an increased inflammatory response over 
‘fine particles’ (diameter  ~250 nm) per unit mass.42, 43   Here, Oberdorster et al attributed
the origin of this difference to the larger ratio of surface to mass inherently present in 
ultrafine particles over fine particles.42 Note that in the work of Oberdorster et al. surface 
area was defined per mass of sample, whereas for the work presented in this paper 
surface area is defined per particle.  This difference in the definition of particle 
characteristics results in Oberdorster et al. concluding that for a given mass of sample 
that the smaller particles will be more disruptive.  In this paper, surface area is defined 
per particle, resulting in the conclusion that for a given number of nanoparticles, the 
larger particles (r = 1.5-25 nm) which have greater surface area) are more disruptive.  
Note that with the exception of silica amine nanoparticles, also nanoparticles investigated 
within this study as well as the one presented by Ginzburg and Balijepalli fall within the 
ultrafine particle regime (r = 0-20 nm).  Although surface area is a general parameter for 
predicting how cationic nanoparticles interact with SLBs, the trends presented here 
indicate that it is not the only important parameter.   The nanoparticle-SLB interactions 
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are likely also dependent on a number of other parameters including charge density, 
shape, and flexibility.  
4.4 CONCLUSION 
This results presented in this paper demonstrate that disruption of lipid bilayers is 
a common property of cationic nanoparticles.   Each cationic nanoparticle presented here, 
regardless of shape (spherical vs. irregular), chemical composition (organic vs. 
inorganic), deformability (flexible vs. rigid), charge density, or size, disrupts supported 
lipid bilayers.  Our previously published studies demonstrated that effectiveness of a 
particle in causing nanoscale disruption of supported lipid bilayers correlated well the 
particle’s ability to both induce cell membrane permeability and to internalize into the 
cell.10, 12, 13  The data presented here indicates that the hypothesis that nanoscale hole 
formation may be a biologically relevant process should be extended to a variety of 
additional materials including MSI-78, TAT, and cationic gold and silica particles.  The 
generality of the bilayer disruption is extremely important because many examples of 
natural and synthetic nanoparticles utilize amine terminations to achieve water solubility 
and other functions.    Given the growing use of nanoparticles in consumer products, 
industrial applications and in medicine, it is imperative that we understand observed and 




Figure 4.1a-d.  (1a).  Space filling model of MSI-78, a 22 amino acid protein with 9 of those residues 
positively charged at pH 7.2.  MSI-78 were injected onto a DMPC lipid bilayer (1b) resulting in a final 
concentration of ~450 nM (1.2 mg/mL) MSI-78.  Subsequent images over ~40 minutes were obtained (1c-
d) which showed the removal of lipid, primarily through the expansion of pre-existing defects as seen with 
G5-NH2 dendrimers.  Note that the perimeter surrounding the defects is ~1 nm thinner then the full lipid 
bilayer (~5 nm).  This ‘thinning effect’ is consistent with what had been previously shown at lower 
concentration of MSI-78 (2 μg/mL) and suggests that the thinning of the bilayer precedes full removal of 
lipid.  Scale bar is 500 nm.   
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Figure 4.2a-d.  (4.2a) Space-filling model of TAT, a 275 amino acid protein with 50 of those residues 
positively charged at pH 7.2.  TAT protein was injected onto a DMPC lipid bilayer (4.2b) yielding a final 
concentration of 300 nN (10 μg/mL) TAT.  Subsequent images (4.2c-d) taken over a period of 20 minutes 
showed the formation and expansion of defects in the bilayer.  Scale bar is 500 nm.   
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Figure 4.3a-d (4.3a) G3-NH2 dendron (16e+) primarily expanding pre-existing defects, eventually 
accumulating around the edges (4.3b) G3-NH2 (32e+) accumulated around the edges of pre-existing defects 
(4.3c) G5-NH2 (128e+) primarily expanded pre-existing defects, eventually accumulating around the edges 
and (4.3d) G7-NH2 (512 e+) primarily induced the formation of defects on lipid terraces.  (4.3a) G3-NH2
dendron concentration was ~100 nM (G3-NH2 dendron = 0.04 μg/mL).  Dendrimer concentrations used 
were ~25 nM (4.3b-d) (G3-NH2 = 0.01 μg/mL; G5-NH2 = 0.07 μg/mL; G7-NH2 = 3 μg/mL.  Scale bars are 
500 nm. (Dendrimer work was completed by Almut Mecke).
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Figure 4.4a-d.  PEI (Mw: 78,220, PDI: 3.44, d = 6.6 nm) and DEAE-DEX (Mw: 18,490; PDI: 3.290, d = 
4.2 nm) were injected onto DMPC supported lipid bilayers (4.4c and 4.4d, respectively) yielding a final 
concentration of 1 μg/mL polymer in both cases.  Images following injection showed that PEI expanded 
pre-existing defects (4.4e) similar to what was seen with the G5-NH2 while DEAE-DEX induced thinning 
of the bilayer similar to what was seen with MSI-78 at low concentration (4.4d).  Note that diameters were 
based on the Mw values and assuming a spherical shape with a density of 1.0 g/cm3.  Scale bars are 500 nm.   
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Figure 4.5a-c. Au-NH2 nanoparticles (4.5a) were injected onto a DMPC supported lipid bilayer (4.5b) 
yielding a final concentration of ~500 nM (44 μg/mL) Au-NH2.  The Au-NH2 nanoparticles expanded pre-
existing defects within the supported lipid bilayer and appeared to aggregate on the mica surface (4.5c)   
Scale bar is 500 nm.   
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Figure 4.6a-c.  50 nm amine coated silica spheres (~13,000 NH2/sphere) (4.6a) were introduced onto a 
DMPC lipid bilayer (4.6b) yielding a final concentration of ~3 mg/mL (30 nM) of the silica spheres.  The 
addition of the positively charged spheres resulted in the formation of circular defects on the bilayer 
ranging from 20-150 nm in diameter (4.6c).  The formation of the new defects within the bilayer is similar 
to what was seen with G7-NH2 PAMAM dendrimers.  Scale bar is 500 nm.    
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CHAPTER 5 
THE IMPORTANCE OF SUPRAMOLECULAR STRUCTURE FOR 
NANOPARTICLE FUNCTION 
5.1 BACKGROUND 
  The nanoparticles investigated in the previous chapters are formed through 
covalent linkages of their respective sub-parts.  In this Chapter 5, we examine the 
interaction of a type of charged, non-covalently linked ‘nanoparticles’ called micelles.   
Above critical micelle concentration (CMC), detergent molecules self-assemble to form 
micelles which are regular structure similar in size to those nanoparticles investigated in 
Chapters 3-4.  Within this chapter we use atomic force microscopy (AFM) to address, on 
a nanoscale level, the behavior of two common ionic detergents as individual molecules 
(below CMC), as well as in their supramolecular micelle forms (above CMC).  The two 
species discussed, the negatively charged sodium dodecylsulfate (SDS, C12H25SO4Na, 
CMC = 7-10 mM) and the positively charged cetyltrimethylammonium bromide (CTAB, 
C16H33N(CH3)3Br, CMC = 1mM), were chosen because they are well documented to 
disrupt biological membranes above CMC.1 Like the covalently linked nanoparticles 
investigated in the previous chapters, we find that the above CMC charged detergents 
SDS and CTAB remove lipid from SLBs.   Interestingly, pre-existing defects within the 
SLBs are occluded when these same detergents are introduced at concentrations below 
their respective CMCs.  This chapter shows that non-covalently linked nanoparticles 
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induce defects within model cell membranes similar to covalently-linked charged 
nanoparticles. 
The ashen-fat used by the ancient Babylonians to remove mud from their clothes 
is not far removed from the present-day detergents we purchase at the local drug store.  
Indeed, the mechanism by which hydrophobic materials are removed can be explained in 
a simple fashion:  the hydrocarbon chain of the detergent molecule interacts with the 
hydrophobic material and the resulting composite is made soluble in water by the 
presence of the detergent’s hydrophilic head.  However, this explanation masks the fact 
that these molecules function via a supramolecular organization that generates an active 
form, called a micelle, which is on the order of tens of nanometers in size.    The ratio of 
the hydrophobic tail length to hydrophilic head area is the primary parameter that 
determines the size of the micelle  and the critical micelle concentration (CMC).1  Below 
CMC, the surfactant molecules are present as individual molecules in solution.   At the 
CMC, it becomes energetically favorable for the amphiphilic molecules to arrange 
themselves into structures such as spherical micelles and, at higher concentrations, rod-
like structures.   These ordered, nanoscale micelles and rods are the active form of the 
detergent that dissolves oils and other biological entities including membrane 
components such as proteins and lipids.2  
Previous studies have examined the activity of various detergents both below and 
above CMC in the presence of lipid vesicles3-6 and supported lipid bilayers.4, 5, 7 Below 
CMC, single detergent molecules incorporate into the lipid domain, decreasing surface 
tension and enlarging the previously lipid-only domain.2, 4, 5, 7, 8  Above CMC, the 
detergent removes the lipid either by an exchange of detergent molecules between the 
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detergent micelle and lipid domain, or by encapsulation of the lipid by the detergent 
micelle.  This set of experimental observations has been further supported by a theoretical 
analysis that described the interaction as primarily a function of CMC and the 
equilibrium partition coefficient.9  The majority of studies to date employed methods 
which sample macroscopic volumes such as light scattering,10-12  nuclear magnetic 
resonance (NMR),13, 14 radio tracers15 and isothermal titration calorimetry,10, 16, 17 and 
were thus unable to make measurements with nanoscale resolution regarding the 
detergent insertion or erosion process. Recently, Morandant and Kirat published an AFM 
study of the interaction of Triton X-100 with mixed 
dioleoylphosphatidylcholine/dipalmitoylphosphatidylcholine (DOPC/DPPC) supported 
lipid bilayers on mica.7  Triton X-100 (polyoxoethylene(10) isooctylphenyl ether, 4-
(C8H17)C6H4(OCH2CH2)nOH [n = ~10]) is a non-ionic detergent that is highly effective at 
disrupting biological membranes.  In their study, they noted that below CMC Triton X-
100 inserted into the lipid bilayer but did not dissolve it, while above CMC, the detergent 
preferentially dissolved the liquid-phase DOPC regions as compared to the gel-phase 
DPPC regions.  Not only does this demonstrate that form affects function (i.e., single 
molecule vs. micelle), and that lipid phase further mediates this function, it raises 
additional questions regarding the effect of detergent charge.  In particular, how does 
head group charge affect the interaction between lipid and detergent, both in the single-





Sodium dodecyl sulfate (SDS) and cetyltrimethyl ammonium bromide (CTAB) 
were purchased from Sigma-Aldrich.  Solutions of SDS and CTAB above and below 
their respective CMCs were made using deionized water.  The CMCs for SDS and CTAB 
are 7-10 mM and 1 mM, respectively.1   
Images were obtained using either a Nanoscope IIIa MultiMode Scanning Probe 
Microscope (Veeco, Santa Barbara, CA) or a PicoPlus instrument (Molecular Imaging, 
Tempe, AZ).  Imaging was completed using the appropriate liquid cell for each 
instrument.  Silicon nitride cantilevers (NPS (Veeco), spring constant 0.32 N/m) were 
used at a drive frequency of 6-12 kHz.  
5.2.2 Imaging
A 1 mg/mL suspension of small, unilamellar vesicles (SUVs) were prepared as 
previously reported.18  60-80 L of the DMPC liposome suspension was placed on a l cm 
× l cm piece of freshly cleaved mica attached to a metal sample puck by double sided 
tape. After an incubation period of about 20 min, excess lipids were removed by gently 
rinsing with deionized water. The sample was placed in the AFM and imaged to confirm 
that a bilayer had formed.  After it was determined the bilayer was stable (i.e., remained 
unchanged over a period of ~10 minutes), detergent was introduced via a syringe onto the 
surface of the lipid bilayer.  Final concentration of detergent within the liquid was 
estimated based on the molarity of the detergent introduced to the liquid cell divided by 
the total volume of the appropriate liquid cell.  Imaging was performed at 24-25C.  
Under our imaging conditions, the lipids imaged were in the liquid crystalline phase as 
evidenced by the presence, and subsequent disappearance, of the gel crystalline phase 
during the ~10 minute stabilization period.   
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5.2.3 Image Analysis 
Height analysis was completed using each instrument’s respective software and 
exported as JPEGs.  All images (with the exception of Figures 3a and 3b) are displayed 
on a 20 nm scale.  The contrast of Figures 1c and 1d was enhanced using Photoshop to 
yield Figures 3a and 3b.  This was done to enable the reader to more easily distinguish 
the lipid-detergent boundaries.  Root-mean squared (RMS) roughness values were 
calculated using the imaging software, Gywddion.   
 
5.3 RESULTS AND DISCUSSION 
Concentrations of detergent were selected below CMC so that the effects of 
detergent molecules could be studied in the absence of micelles.  When SDS below CMC 
was introduced to a DMPC supported lipid bilayer (SLB), (Figure 1a), pre-existing 
defects were filled (Figure 1b-d).  The occluded regions possess an identical height and 
an equivalent root-mean square (RMS) roughness to that measured on the bilayer regions 
before and after SDS introduction.  When CTAB below CMC was introduced to a 
supported DMPC lipid bilayer, (Figure 2a), the pre-existing defects were once again 
filled (Figure 2b-d).   In contrast to SDS, the CTAB occluded region is ~ 1 nm thinner 
than the lipid bilayer and differed in RMS roughness.  Both SDS and CTAB occlude the 
pre-existing defects in the DMPC SLB and maintain a distinguishable perimeter identical 
in shape to the original bilayer defect.   
To highlight the existence of the persistent boundary between the occluded region 
and the lipid bilayer, a magnified view of the filling of a single defect is provided for both 
SDS and CTAB (Figures 3a and 3b, respectively).  In both cases, it is clear that the defect 
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occluded while maintaining the distinct boundary of the original defect perimeter.  The 
defects appear to occlude by initial interaction of the detergent with the defect edge 
followed by filling to the center.  For both SDS and CTAB, the height and the RMS 
roughness of the occluded region remains constant during the entire filling process.  If 
mixing between lipid and detergent were occurring, we would have expected the original 
defect perimeter to disappear.  Furthermore, if mixing was occurring during the filling 
process, we would have expected the measured height and/or RMS roughness to vary, 
particularly for CTAB occlusion where a ~ 1 nm difference in height is observed.  
However, neither the disappearance of the perimeter nor varying occlusion height was 
observed over the time scale of these experiments.   
Based upon the measured height of the occluded regions, it appears that detergent 
molecules fill the pre-existing membrane defects with a bilayer of detergent.  This is 
consistent with the models of occlusion structure proposed in Fig. 7a for SDS and Fig. 7b 
for CTAB.  Interestingly, this observation differs from the uniform intercalation of 
detergent into lipid vesicles and lipid bilayers that has been proposed previously.5, 8, 9, 13 
These earlier conclusions were reached based on a variety of bulk techniques including 
light scattering,10 and nuclear magnetic resonance.13   The previous AFM studies, which 
concluded that detergent partitioned directly into the lipid bilayer, differed in that the 
published images do not have pre-existing defects present and the detergent employed 
was not charged.7  Unlike the previous AFM studies employing non-ionic detergent, we 
did not observe swelling of the lipid bilayer.  This is additional evidence that charged 
detergent molecules do not partition into the bilayer over the time scale of these 
experiments. The results highlighted in Figures 1 and 2 indicate that non-uniform 
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distribution of detergent is possible and that the lipid bilayer can even template the 
detergent into a bilayer structure.  The C12 methylene chain of SDS should be sufficient 
to provide a bilayer of equivalent thickness to DMPC.  It is perhaps surprising that the 
C16 chain of CTAB results in a 1 nm thinner bilayer.  This suggests that the CTAB 
bilayer is partially interdigitated or has a substantial tilt angle.  Another possible 
interpretation for the occluded regions would involve an admixture of detergent and lipid.  
The AFM data does not directly address the composition of the occlusions and based 
upon the data presented this alternative cannot be ruled out.  However, we believe the 
persistence of the perimeter, consistency of the occlusion height and uniform RMS 
roughness provide substantial evidence against the mixed lipid/detergent hypothesis. 
Experiments were also carried out with concentrations of detergent above the 
CMC such that SDS and CTAB would be in the form of nanoscale micelles.   When SDS 
above CMC was introduced to a DMPC bilayer with pre-existing defects, lipid was 
removed thus increasing the number of 5 nm deep defects present (Figure 4a).   When 
CTAB above CMC was introduced to a similar DMPC bilayer, the perimeter of the pre-
existing bilayer defects grew large (Figure 4b).  However, the depth of the defects 
changes to 2.5 nm.  In order to probe the origin of this change in defect depth, SDS above 
CMC was added to the CTAB-lipid sample, resulting in the formation of the 5 nm depth 
expected for defects in a DMPC bilayer (Figure 5).  This served as confirmation that the 
initial measured 2.5 nm defects were not the result of an overall decrease in the bilayer 
height, but instead the result of a 2.5 nm coating atop the mica inside the defect.  In 
previous studies, we have noted that polycationic polymers will coat mica inside a lipid 
bilayer defect.19  By analogy, we considered two possible models to explain the presence 
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of a 2.5 nm mica coating leading to an observed 2.5 nm defect in the lipid bilayer: (1) a 
monolayer of CTAB with positively charged head-group bound to the negatively charged 
mica and alkyl chains pointing into the water and (2) an interdigitated CTAB bilayer with 
charge head-groups bound to mica and directed toward the water (as shown in Figure 7d).  
In order to better understand the structure of the 2.5 nm layer coating the mica, we 
performed two experiments.  First, we deposited a water solution of CTAB above CMC 
onto mica and observed 2.5 nm high regions (Figure 6).  These have been previously 
characterized as interdigitated, tilted bilayers of CTAB.20  This firmly established that a 
2.5 nm coating of CTAB on mica, and by extension a 2.5 nm defect in DMPC filled with 
CTAB, is consistent with the data illustrated in Figure 5.4b, and was a reasonable 
hypothesis.  Second, we performed a contact angle experiment with a 2.5 nm coating of 
CTAB on mica and found complete wetting by water.  The results of these experiments 
are consistent with model (2) as depicted in Figure 5.7d.  The wetting experiments are 
inconsistent with the presence of a monolayer of CTAB with the alkyl chains oriented 
away from the surface as required by the AFM height measurement.  It is possible that 
the negative charge of the mica substrate chosen may have influenced the behavior of the 
charged detergents.  Indeed, it is likely that the electrostatic interaction between the 
positively charged moiety of the CTAB molecule and the negatively charged mica 
substrate is responsible for CTAB’s tendency to remain on the mica substrate.  Despite 
having opposing charges, both detergents nonetheless interacted with the SLB in very 
similar fashions.  This indicates that both the occlusion and erosion interactions observed 
are common properties of charged detergents.    
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Despite the similarity in behavior between these self-aggregated micelles and the 
covalently linked nanoparticles, it is not clear that their respective mechanisms of lipid 
removal are the same.  As discussed in the beginning of this chapter, detergent micelles 
remove lipid either by an exchange of detergent molecules between the detergent micelle 
and lipid domain, or by encapsulation of the lipid by the detergent micelle.  Clearly, no 
such exchange occurs during lipid removal by the covalently-linked nanoparticles.  
However, lipid may bind to the surface of the charged nanoparticle, integrating itself 
within the nanoparticle structure as shown below (Figure 5.8).  Using a PAMAM 
dendrimer as example, we see that this structure vaguely resembles a mixed lipid-
detergent micelle (Figure 5.8).  One can imagine that larger nanoparticles would be more 
effective at removing lipid than smaller nanoparticles at equimolar concentrations 
because of the additional space available for the lipid molecules to bind.  A trend 
showing increased hole formation activity with increased nanoparticle size has been 
shown by Hong et al using PAMAM dendrimers, and is consistent with this argument.21  
However, there is also evidence for an optimal nanoparticle size for lipid removal which 
runs contrary to this argument.22 More detailed mechanistic studies examining the 
removal lipid by nanoparticles must be completed before mechanistic analogies such as 
these are given serious credence.  These studies, in the form of atomistic simulations 






In this chapter, two major observations are presented.  First, solutions of charged 
detergents below CMC, as exemplified by SDS and CTAB, did not erode, insert into, 
and/or induce holes in DMPC supported lipid bilayers over the ~10 minute time scale of 
the experiments.  However, the defects present were occluded by the detergent.   Second, 
solutions of charged detergents above CMC did erode lipid bilayers over a ~ 10 minute 
time scale.  The defects formed in the SLBs by these non-covalently linked nanoparticles 
were very similar to those defects formed by the more traditional nanoparticles 
investigated in Chapters 3-4. This shows that non-covalent aggregations of charged 








Figure 5.1.  SDS below CMC (0.04 mM) introduced to DMPC mica-SLB with pre-existing defects.  (a) 
Image before SDS addition. (b-d) Images post SDS addition.  Arrows highlight lipid-detergent boundary.  
Scale bar 500 nm.
 
 
Figure 5.2.   CTAB below CMC (0.1 mM) introduced to DMPC mica-SLB with pre-existing defects.  (a) 
Image before SDS addition. (b-d) Images post CTAB addition.  Arrows highlight lipid-detergent boundary.  









Figure 5.3.  Zoomed in image of  (a) 1c and (b) 2c highlighting persistent lipid-detergent boundaries for 
SDS and CTAB, respectively. 
 
Figure 5.4.  (a) DMPC mica-SLB after addition of SDS above CMC (20 mM).  (b) DMPC mica-SLB after 




Figure 5.5.  (a) DMPC mica-SLB after addition of CTAB above CMC (5 mM).  (b) After addtion of SDS 










Figure 5.7.  (a) Below CMC, SDS occludes defects.  (b) Below CMC, CTAB occludes defects.  (c)  Above 
CMC, SDS removes lipid from bilayer.  (d) Above CMC, CTAB removes lipid leaving a CTAB bilayer.   
Note in all cases the tilt angle of the detergent bilayer (a, b, d) is not ascertained from these studies.  CTAB 




Figure 5.8 (a) Lipid (purple) intercalated into a charged detergent micelle (blue)  and (b) lipid intercalated 
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CONCLUSIONS AND OUTLOOK 
  This dissertation has examined the interactions of targeted and non-targeted 
nanoparticles with cells and model membranes.  The force pulling studies presented 
within Chapter 2 showed that in the presence of free FA, the number of binding events 
between the multivalent targeted nanodevice G5-Ac70-FA7.2 significantly decreased.  
Interestingly, however, the average rupture force under these free FA blocking conditions 
was significantly higher than under non-blocking conditions.   Due to the expected 
distributions of FAs present on the surface of the G5-Ac70-FAn, we are not at this point 
able to make conclusions regarding the difference in binding seen between G5-Ac70-
FA2.7, and G5-Ac70-FA4.7 and  G5-Ac70-FA7.2.   
 Chapters 3-5 examine the interaction of a variety of charged nanoparticles with a 
model membrane using atomic force microscopy (AFM).  Each of the covalently-linked 
cationic nanoparticle investigated, regardless of shape (spherical vs. irregular), chemical 
composition (organic vs. inorganic), deformability (flexible vs. rigid), charge density, or 
size, disrupted supported lipid bilayers. It was shown that the degree of membrane 
disruption tracked grossly with nanoparticle surface area.  In addition, Chapter 5 shows 
the non-covalently linked charged nanoparticles in the form of detergent micelles behave 
similarly to the covalently-linked nanoparticles investigated in Chapters 3-4.  The 
formation of defects on the model membranes by charged nanoparticles is consistent with 
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cell-level studies and suggests that hole formation within the membrane is one of the 
mechanisms through which nanoparticles are internalized and/or induce toxicity.
  There are several ways in which to improve our understanding of targeted 
multivalent platforms, G5-FAn. First, it is necessary to repeat these studies with a 
number of tips for each G5-FAn.  The studies presented here relied on the measurements 
obtained from a single tip for each G5-FAn.  Given the expected distributions of FA on 
the surface of the dendrimer scaffold, it is simply necessary if we are to draw any 
conclusion regarding the distribution of binding configurations.  Second, we could 
perform the force pulling studies on a G5-FA1 or equivalent model to determine if the 
dislocations presented in Chapter 2 represent, as hypothesized, a single FA unbinding 
from the FBP substrate.  The synthetic difficulties associated with making a G5-FA1
would likely require a substitution of some sort.  For example, one could imagine 
forgoing the dendrimer altogether and attaching a FA to the focal point of a dendron, or 
to the end of the PEG linker.  Although this does introduce a new variable (the effect of 
the G5 itself), theoretically it should not alter the force required to rupture the FA-FBP 
bond. Third, we could obtain absolute forces of unbinding using dynamic force 
microscopy.  The study completed in Chapter 2 yielded relative forces which is 
acceptable when comparing rupture forces within a single system.  However, if we had 
interest in comparing our G5-FAn system to other multivalent systems, we would need to 
obtain absolute forces.  As a final suggestion for improving the force pulling studies, we 
could orient the FBP on the substrate.  By orienting the FBP on the substrate, we could be 
sure that we were measuring the variation in the number of FAs binding, and not simply 
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the difference in binding strength due to the variation in the orientation of the receptor 
itself.   
The intention of Chapters 3-5 was to determine which physical parameters dictate 
whether a nanoparticle will breach a cellular membrane.  Suffice it to say, the simplicity 
of this goal masked the complexity of the problem.  It was hypothesized that charge 
density played a significant role in the nanoparticle-membrane interaction, so much so 
that the other parameters could be considered secondary.  This hypothesis was driven by 
our observation that PAMAM dendrimers of higher generations (e.g., G7) were more 
effective at inducing defects than small generations (e.g., G3 and G5).  Interestingly, 
however, it did not appear that charge density dominated nanoparticle-membrane 
interactions.  Instead, it was nanoparticle surface area that tracked best with the degree of 
membrane disruption.  That said, this trend was far from exact and it is very likely that 
other physical parameters such as charge density help mediate nanoparticle-membrane 
interactions.   
  One tactic for teasing out the effect of each of the physical parameters would be 
to systematically vary one parameter more carefully.  Unfortunately, systematically 
varying any parameter is not trivial for most synthetic nanoparticles.  However, PAMAM 
dendrimers do lend themselves nicely to this line of experimentation.   For example, the 
G7 PAMAM dendrimer has nominally 512 primary amines and largely induces the 
formation of defects whereas G3 PAMAM dendrimer has nominally 16 primary amines 
and does little more than aggregate around pre-existing defects.  By acetylating 496 of 
the G7’s primary amines, we can directly compare the effect of size.  Similarly, one can 
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imagine varying the percentage of amine groups acetylated for a particular dendrimer 
generation and examining how this effects the dendrimer interaction both with 
membranes  It is possible that this type of one-parameter variation could be applied to 
other systems such as modified gold nanoparticles.  For example, one could 
systematically vary the size of the gold core while maintain the number of alkyl amine 
groups on the surface.  These studies should be completed using both the AFM/SLB 
assay, as well as the more traditional cell-level assays in order to obtain a more complete 
picture of the interactions. Although this line of study would be tedious, it would yield a 
much clearer understanding of the how the physical parameters of nanoparticles affect 
their interaction with membranes.   
As manufacturers increasingly push the limits of how small conventional 
materials can be made, materials of nanoscale size are becoming more and more 
important.  Although the fabrication of new goods is generally good, our understanding 
of the interaction between nanoparticles and their environment has not yet caught up with 
our technology.  The short time frame over which manufactured nanomaterials have been 
developed has not allowed us to fully understand their associated toxicity, the importance 
of which is just beginning to be appreciated.  As such, there remains a great deal of study 
to be done not only on those particles already utilized, but also on those currently being 
developed.   While it is only natural to search for new ways to improve products, we must 
nonetheless remain cognizant of the potential dangers associated with technological 
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